| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCA1 MYH11 MYO5B ATP8A2 PSMC1 PSMC3 PSMC6 SRPRA ABCA9 MDN1 SUPV3L1 NAV3 MLH1 KIF5B KIF11 ABCC1 CCT4 MSH3 ATP8B2 ATP6V0A4 MYH15 DDX53 ATP2B1 | 3.97e-07 | 614 | 222 | 23 | GO:0140657 |
| GeneOntologyMolecularFunction | actin filament binding | MYH11 CTNNAL1 MYO5B ACTN3 IQGAP1 IQGAP3 PLS3 SYNE1 LCP1 SHROOM2 FMNL3 MYH15 CTNNA1 | 1.66e-06 | 227 | 222 | 13 | GO:0051015 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCA1 MYO5B ATP8A2 PSMC1 PSMC3 PSMC6 SRPRA ABCA9 MDN1 SUPV3L1 NAV3 MLH1 KIF5B ABCC1 CCT4 ATP8B2 DDX53 ATP2B1 | 2.35e-06 | 441 | 222 | 18 | GO:0016887 |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | CTNNAL1 ERC1 CKAP5 ITGA2 ACTN3 ITGAD ITGAM IQGAP1 DST KDR KIF5B CNGA3 GOLGA3 JAM3 RANGAP1 BAG3 LCP1 PDIA4 ITGB1BP2 CTNNA1 TNXB | 3.69e-06 | 599 | 222 | 21 | GO:0050839 |
| GeneOntologyMolecularFunction | integrin binding | ITGA2 ACTN3 ITGAD ITGAM DST KDR JAM3 LCP1 PDIA4 ITGB1BP2 TNXB | 4.35e-06 | 175 | 222 | 11 | GO:0005178 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ABCA1 MYO5B ATP8A2 PSMC1 PSMC3 PSMC6 SRPRA ABCA9 MDN1 RHOBTB1 SUPV3L1 NAV3 MLH1 KIF5B GTPBP3 ABCC1 CCT4 ATP8B2 ARHGAP5 MTIF2 DDX53 GFM1 ATP2B1 | 1.90e-05 | 775 | 222 | 23 | GO:0017111 |
| GeneOntologyMolecularFunction | proteasome-activating activity | 2.65e-05 | 6 | 222 | 3 | GO:0036402 | |
| GeneOntologyMolecularFunction | GTPase binding | ABCA1 MYO5B ERC1 IQGAP1 PARD6A DIAPH2 GCC1 IQGAP3 PKN3 RANGAP1 IFT20 LCP1 FMNL3 GCC2 | 5.41e-05 | 360 | 222 | 14 | GO:0051020 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ABCA1 MYO5B ATP8A2 PSMC1 PSMC3 PSMC6 SRPRA ABCA9 MDN1 RHOBTB1 SUPV3L1 NAV3 MLH1 KIF5B GTPBP3 ABCC1 CCT4 ATP8B2 ARHGAP5 MTIF2 DDX53 GFM1 ATP2B1 | 6.47e-05 | 839 | 222 | 23 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ABCA1 MYO5B ATP8A2 PSMC1 PSMC3 PSMC6 SRPRA ABCA9 MDN1 RHOBTB1 SUPV3L1 NAV3 MLH1 KIF5B GTPBP3 ABCC1 CCT4 ATP8B2 ARHGAP5 MTIF2 DDX53 GFM1 ATP2B1 | 6.59e-05 | 840 | 222 | 23 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ABCA1 MYO5B ATP8A2 PSMC1 PSMC3 PSMC6 SRPRA ABCA9 MDN1 RHOBTB1 SUPV3L1 NAV3 MLH1 KIF5B GTPBP3 ABCC1 CCT4 ATP8B2 ARHGAP5 MTIF2 DDX53 GFM1 ATP2B1 | 6.59e-05 | 840 | 222 | 23 | GO:0016818 |
| GeneOntologyMolecularFunction | small GTPase binding | ABCA1 MYO5B ERC1 IQGAP1 PARD6A DIAPH2 GCC1 IQGAP3 PKN3 RANGAP1 IFT20 FMNL3 GCC2 | 6.65e-05 | 321 | 222 | 13 | GO:0031267 |
| GeneOntologyMolecularFunction | protein-folding chaperone binding | 8.17e-05 | 161 | 222 | 9 | GO:0051087 | |
| GeneOntologyMolecularFunction | actin binding | MYH11 CTNNAL1 MYO5B ACTN3 IQGAP1 DST DIAPH2 IQGAP3 PLS3 HDAC6 SYNE1 LCP1 SHROOM2 FMNL3 MYH15 CTNNA1 | 9.70e-05 | 479 | 222 | 16 | GO:0003779 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYH11 CTNNAL1 MYO5B CKAP5 CLSTN2 ACTN3 JAKMIP2 IQGAP1 DST DIAPH2 NAV3 KIF5B CNGA3 IQGAP3 PLS3 KIF11 HDAC6 SYNE1 NUMA1 LCP1 SHROOM2 FMNL3 SMTNL1 PDCD5 MYH15 CTNNA1 | 2.33e-04 | 1099 | 222 | 26 | GO:0008092 |
| GeneOntologyMolecularFunction | calcium ion binding | FKBP9 CLSTN2 ACTN3 IQGAP1 DST HMCN2 PLS3 FKBP10 PCLO CAPS PCDHB10 PCDHB9 PCDHB2 CASQ1 CRTAC1 PCDHA4 LCP1 ITGB1BP2 NINL PLCH1 | 2.78e-04 | 749 | 222 | 20 | GO:0005509 |
| GeneOntologyMolecularFunction | ATPase regulator activity | 3.30e-04 | 54 | 222 | 5 | GO:0060590 | |
| GeneOntologyMolecularFunction | adenyl-nucleotide exchange factor activity | 5.59e-04 | 15 | 222 | 3 | GO:0000774 | |
| GeneOntologyMolecularFunction | FMN binding | 6.82e-04 | 16 | 222 | 3 | GO:0010181 | |
| GeneOntologyMolecularFunction | floppase activity | 6.82e-04 | 16 | 222 | 3 | GO:0140328 | |
| GeneOntologyMolecularFunction | guanine/thymine mispair binding | 7.28e-04 | 4 | 222 | 2 | GO:0032137 | |
| GeneOntologyMolecularFunction | apolipoprotein binding | 1.34e-03 | 20 | 222 | 3 | GO:0034185 | |
| GeneOntologyMolecularFunction | phosphatidylcholine transporter activity | 1.34e-03 | 20 | 222 | 3 | GO:0008525 | |
| GeneOntologyMolecularFunction | sphingolipid transporter activity | 1.34e-03 | 20 | 222 | 3 | GO:0046624 | |
| GeneOntologyMolecularFunction | cadherin binding | CTNNAL1 ERC1 CKAP5 IQGAP1 KDR KIF5B CNGA3 GOLGA3 RANGAP1 BAG3 CTNNA1 | 1.51e-03 | 339 | 222 | 11 | GO:0045296 |
| GeneOntologyMolecularFunction | microtubule plus-end binding | 1.79e-03 | 22 | 222 | 3 | GO:0051010 | |
| GeneOntologyMolecularFunction | MAP kinase kinase kinase kinase activity | 1.79e-03 | 6 | 222 | 2 | GO:0008349 | |
| GeneOntologyBiologicalProcess | regulation of protein folding | 1.18e-05 | 14 | 221 | 4 | GO:1903332 | |
| GeneOntologyBiologicalProcess | protein folding | FKBP9 SACS ST13P5 FKBP10 BAG5 AHSA2P BAG3 CCT4 SIL1 PDIA4 CDC37 PDCD5 | 1.47e-05 | 246 | 221 | 12 | GO:0006457 |
| GeneOntologyBiologicalProcess | cell junction organization | MYO5B ERC1 CKAP5 CLSTN2 ITGA2 ACTN3 ITGAM IQGAP1 ARHGAP22 DST HMCN2 PARD6A KDR KIF5B JAM3 HDAC6 PCLO PCDHB10 PCDHB9 PCDHB2 CRTAC1 SHROOM2 CSK CTNNA1 PEAK1 PARD3 | 1.76e-05 | 974 | 221 | 26 | GO:0034330 |
| GeneOntologyBiologicalProcess | inclusion body assembly | 2.51e-05 | 33 | 221 | 5 | GO:0070841 | |
| GeneOntologyBiologicalProcess | negative regulation of protein folding | 4.11e-05 | 7 | 221 | 3 | GO:1903333 | |
| GeneOntologyCellularComponent | supramolecular fiber | MYH11 EPPK1 CKAP5 ACTN3 IQGAP1 AKAP4 DST DIAPH2 NAV3 KIF5B NOS1 PLS3 JAM3 KIF11 COL6A3 KRT78 HDAC6 SYNE1 BAG3 NUMA1 OBSL1 CASQ1 CCT4 LCP1 SHROOM2 SMTNL1 RTL1 ITGB1BP2 NINL MYH15 | 6.77e-06 | 1179 | 220 | 30 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | MYH11 EPPK1 CKAP5 ACTN3 IQGAP1 AKAP4 DST DIAPH2 NAV3 KIF5B NOS1 PLS3 JAM3 KIF11 COL6A3 KRT78 HDAC6 SYNE1 BAG3 NUMA1 OBSL1 CASQ1 CCT4 LCP1 SHROOM2 SMTNL1 RTL1 ITGB1BP2 NINL MYH15 | 7.73e-06 | 1187 | 220 | 30 | GO:0099081 |
| GeneOntologyCellularComponent | I band | 1.08e-05 | 166 | 220 | 10 | GO:0031674 | |
| GeneOntologyCellularComponent | contractile muscle fiber | MYH11 ACTN3 AKAP4 DST NOS1 SYNE1 BAG3 OBSL1 CASQ1 SMTNL1 RTL1 ITGB1BP2 MYH15 | 1.32e-05 | 290 | 220 | 13 | GO:0043292 |
| GeneOntologyCellularComponent | PAR polarity complex | 2.25e-05 | 6 | 220 | 3 | GO:0120157 | |
| GeneOntologyCellularComponent | Z disc | 3.26e-05 | 151 | 220 | 9 | GO:0030018 | |
| GeneOntologyCellularComponent | myofibril | ACTN3 AKAP4 DST NOS1 SYNE1 BAG3 OBSL1 CASQ1 SMTNL1 RTL1 ITGB1BP2 MYH15 | 3.45e-05 | 273 | 220 | 12 | GO:0030016 |
| GeneOntologyCellularComponent | cell cortex | MYO5B ERC1 PARD6G ACTN3 IQGAP1 DST HMCN2 PARD6A RAPGEF3 IQGAP3 PCLO NUMA1 SHROOM2 PARD3 | 4.16e-05 | 371 | 220 | 14 | GO:0005938 |
| GeneOntologyCellularComponent | sarcomere | ACTN3 AKAP4 DST NOS1 SYNE1 BAG3 OBSL1 CASQ1 SMTNL1 RTL1 ITGB1BP2 | 7.01e-05 | 249 | 220 | 11 | GO:0030017 |
| GeneOntologyCellularComponent | proteasome regulatory particle, base subcomplex | 2.36e-04 | 12 | 220 | 3 | GO:0008540 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 3.89e-04 | 59 | 220 | 5 | GO:0098636 | |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH11 MYO5B ACTN3 IQGAP1 DST RAPGEF3 DIAPH2 PLS3 JAM3 BAG3 LCP1 SHROOM2 SMTNL1 MYH15 CTNNA1 PEAK1 | 4.18e-04 | 576 | 220 | 16 | GO:0015629 |
| GeneOntologyCellularComponent | cortical cytoskeleton | 4.39e-04 | 129 | 220 | 7 | GO:0030863 | |
| GeneOntologyCellularComponent | somatodendritic compartment | MYO5B CKAP5 SREBF2 CLSTN2 CYP46A1 HMCN2 SACS PARD6A RAPGEF3 KCNJ12 KDR KIF5B NOS1 CNGA3 RANGAP1 HTR1F HDAC6 IFT20 SYNE1 PCLO NTS NUMA1 SHROOM2 KCNJ18 PARD3 ATP2B1 | 5.47e-04 | 1228 | 220 | 26 | GO:0036477 |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 6.16e-04 | 223 | 220 | 9 | GO:0098862 | |
| GeneOntologyCellularComponent | NELF complex | 6.52e-04 | 4 | 220 | 2 | GO:0032021 | |
| GeneOntologyCellularComponent | microtubule end | 6.66e-04 | 38 | 220 | 4 | GO:1990752 | |
| GeneOntologyCellularComponent | basal part of cell | ABCA1 CNNM2 EPPK1 ITGA2 IQGAP1 DST RAPGEF3 MAP4K2 ABCC1 ATP6V0A4 MTTP ATP2B1 | 7.02e-04 | 378 | 220 | 12 | GO:0045178 |
| GeneOntologyCellularComponent | P-body | 7.38e-04 | 102 | 220 | 6 | GO:0000932 | |
| GeneOntologyCellularComponent | actin filament | 9.16e-04 | 146 | 220 | 7 | GO:0005884 | |
| GeneOntologyCellularComponent | cell cortex region | 1.27e-03 | 45 | 220 | 4 | GO:0099738 | |
| GeneOntologyCellularComponent | basal plasma membrane | ABCA1 CNNM2 EPPK1 IQGAP1 DST RAPGEF3 MAP4K2 ABCC1 ATP6V0A4 MTTP ATP2B1 | 1.38e-03 | 354 | 220 | 11 | GO:0009925 |
| GeneOntologyCellularComponent | apical junction complex | 1.45e-03 | 158 | 220 | 7 | GO:0043296 | |
| GeneOntologyCellularComponent | proteasome regulatory particle | 1.53e-03 | 22 | 220 | 3 | GO:0005838 | |
| GeneOntologyCellularComponent | CCR4-NOT core complex | 1.61e-03 | 6 | 220 | 2 | GO:0030015 | |
| GeneOntologyCellularComponent | dendrite | MYO5B CKAP5 SREBF2 CLSTN2 CYP46A1 SACS KCNJ12 KIF5B NOS1 CNGA3 RANGAP1 HTR1F HDAC6 IFT20 SYNE1 PCLO NUMA1 KCNJ18 ATP2B1 | 1.88e-03 | 858 | 220 | 19 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | MYO5B CKAP5 SREBF2 CLSTN2 CYP46A1 SACS KCNJ12 KIF5B NOS1 CNGA3 RANGAP1 HTR1F HDAC6 IFT20 SYNE1 PCLO NUMA1 KCNJ18 ATP2B1 | 1.93e-03 | 860 | 220 | 19 | GO:0097447 |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | ABCA1 MYO5B PSMC3 CTIF ITGA2 AKAP4 DST RAPGEF3 KIF5B NOS1 PKN3 RANGAP1 HDAC6 SYNE1 PCLO BAG5 OBSL1 LCP1 CCAR1 GSDMA | 2.12e-03 | 934 | 220 | 20 | GO:0048471 |
| GeneOntologyCellularComponent | proteasome accessory complex | 2.23e-03 | 25 | 220 | 3 | GO:0022624 | |
| GeneOntologyCellularComponent | inclusion body | 2.63e-03 | 90 | 220 | 5 | GO:0016234 | |
| GeneOntologyCellularComponent | bicellular tight junction | 2.66e-03 | 131 | 220 | 6 | GO:0005923 | |
| GeneOntologyCellularComponent | condensed nuclear chromosome | 2.76e-03 | 91 | 220 | 5 | GO:0000794 | |
| GeneOntologyCellularComponent | lateral part of cell | 2.96e-03 | 8 | 220 | 2 | GO:0097574 | |
| GeneOntologyCellularComponent | cytoskeleton of presynaptic active zone | 2.96e-03 | 8 | 220 | 2 | GO:0048788 | |
| GeneOntologyCellularComponent | microtubule plus-end | 3.10e-03 | 28 | 220 | 3 | GO:0035371 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | EPPK1 CKAP5 ACTN3 IQGAP1 DST DIAPH2 NAV3 KIF5B PLS3 JAM3 KIF11 KRT78 HDAC6 NUMA1 CCT4 LCP1 SHROOM2 SMTNL1 NINL | 3.15e-03 | 899 | 220 | 19 | GO:0099513 |
| Domain | P-loop_NTPase | DCAKD ABCA1 MYH11 THNSL1 MYO5B PSMC1 PSMC3 PSMC6 SRPRA ABCA9 IQGAP1 MDN1 RHOBTB1 SUPV3L1 NAV3 KIF5B GTPBP3 KIF11 NLRP13 ABCC1 MTHFD1L MSH3 ARHGAP5 NLRP14 MTIF2 MYH15 DDX53 GFM1 | 5.23e-07 | 848 | 215 | 28 | IPR027417 |
| Domain | CH | 7.78e-07 | 65 | 215 | 8 | SM00033 | |
| Domain | CH | 1.38e-06 | 70 | 215 | 8 | PF00307 | |
| Domain | - | 1.55e-06 | 71 | 215 | 8 | 1.10.418.10 | |
| Domain | CH | 1.91e-06 | 73 | 215 | 8 | PS50021 | |
| Domain | CH-domain | 2.36e-06 | 75 | 215 | 8 | IPR001715 | |
| Domain | ACTININ_2 | 5.48e-06 | 23 | 215 | 5 | PS00020 | |
| Domain | ACTININ_1 | 5.48e-06 | 23 | 215 | 5 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 5.48e-06 | 23 | 215 | 5 | IPR001589 | |
| Domain | 26S_Psome_P45 | 2.93e-05 | 6 | 215 | 3 | IPR005937 | |
| Domain | VWFA | 4.44e-05 | 82 | 215 | 7 | PS50234 | |
| Domain | AAA | 4.46e-05 | 144 | 215 | 9 | SM00382 | |
| Domain | AAA+_ATPase | 4.46e-05 | 144 | 215 | 9 | IPR003593 | |
| Domain | VWA | 5.19e-05 | 84 | 215 | 7 | SM00327 | |
| Domain | - | DCAKD ABCA1 THNSL1 PSMC1 PSMC3 PSMC6 SRPRA ABCA9 MDN1 RHOBTB1 SUPV3L1 NAV3 GTPBP3 NLRP13 ABCC1 MTHFD1L MSH3 ARHGAP5 NLRP14 MTIF2 DDX53 GFM1 | 5.28e-05 | 746 | 215 | 22 | 3.40.50.300 |
| Domain | EFh | 9.16e-05 | 158 | 215 | 9 | SM00054 | |
| Domain | FG_GAP | 1.06e-04 | 22 | 215 | 4 | PS51470 | |
| Domain | K_chnl_inward-rec_Kir2.2 | 1.32e-04 | 2 | 215 | 2 | IPR003272 | |
| Domain | VWF_A | 1.48e-04 | 99 | 215 | 7 | IPR002035 | |
| Domain | FG-GAP | 1.51e-04 | 24 | 215 | 4 | PF01839 | |
| Domain | FG-GAP | 1.51e-04 | 24 | 215 | 4 | IPR013517 | |
| Domain | EF-hand_1 | 3.84e-04 | 152 | 215 | 8 | PF00036 | |
| Domain | K_chnl_inward-rec_Kir_N | 3.93e-04 | 3 | 215 | 2 | IPR013673 | |
| Domain | RasGAP_C | 3.93e-04 | 3 | 215 | 2 | IPR000593 | |
| Domain | IRK_N | 3.93e-04 | 3 | 215 | 2 | PF08466 | |
| Domain | RasGAP_C | 3.93e-04 | 3 | 215 | 2 | PF03836 | |
| Domain | LUC7 | 3.93e-04 | 3 | 215 | 2 | PF03194 | |
| Domain | Luc7-rel | 3.93e-04 | 3 | 215 | 2 | IPR004882 | |
| Domain | VWA | 4.57e-04 | 56 | 215 | 5 | PF00092 | |
| Domain | Histone_H2A_CS | 6.18e-04 | 15 | 215 | 3 | IPR032458 | |
| Domain | Integrin_alpha_C_CS | 7.54e-04 | 16 | 215 | 3 | IPR018184 | |
| Domain | Alpha_catenin | 7.79e-04 | 4 | 215 | 2 | IPR001033 | |
| Domain | MAPKKKK | 7.79e-04 | 4 | 215 | 2 | IPR021160 | |
| Domain | - | 7.79e-04 | 4 | 215 | 2 | 1.20.58.120 | |
| Domain | Calsequestrin | 7.79e-04 | 4 | 215 | 2 | IPR001393 | |
| Domain | Histone_H2A_C | 9.08e-04 | 17 | 215 | 3 | IPR032454 | |
| Domain | Histone_H2A_C | 9.08e-04 | 17 | 215 | 3 | PF16211 | |
| Domain | EF_Hand_1_Ca_BS | 9.72e-04 | 175 | 215 | 8 | IPR018247 | |
| Domain | Integrin_alpha-2 | 1.08e-03 | 18 | 215 | 3 | IPR013649 | |
| Domain | INTEGRIN_ALPHA | 1.08e-03 | 18 | 215 | 3 | PS00242 | |
| Domain | Integrin_alpha2 | 1.08e-03 | 18 | 215 | 3 | PF08441 | |
| Domain | Integrin_alpha | 1.08e-03 | 18 | 215 | 3 | IPR000413 | |
| Domain | Int_alpha | 1.27e-03 | 19 | 215 | 3 | SM00191 | |
| Domain | Myosin-like_IQ_dom | 1.27e-03 | 19 | 215 | 3 | IPR027401 | |
| Domain | - | 1.27e-03 | 19 | 215 | 3 | 4.10.270.10 | |
| Domain | Int_alpha_beta-p | 1.27e-03 | 19 | 215 | 3 | IPR013519 | |
| Domain | BAG | 1.29e-03 | 5 | 215 | 2 | PS51035 | |
| Domain | Vinculin | 1.29e-03 | 5 | 215 | 2 | PF01044 | |
| Domain | Myosin_S1_N | 1.29e-03 | 5 | 215 | 2 | IPR008989 | |
| Domain | RNase_CAF1 | 1.29e-03 | 5 | 215 | 2 | IPR006941 | |
| Domain | BAG | 1.29e-03 | 5 | 215 | 2 | PF02179 | |
| Domain | CAF1 | 1.29e-03 | 5 | 215 | 2 | PF04857 | |
| Domain | BAG_domain | 1.29e-03 | 5 | 215 | 2 | IPR003103 | |
| Domain | BAG | 1.29e-03 | 5 | 215 | 2 | SM00264 | |
| Domain | EF_HAND_2 | 1.47e-03 | 231 | 215 | 9 | PS50222 | |
| Domain | EF_hand_dom | 1.51e-03 | 232 | 215 | 9 | IPR002048 | |
| Domain | - | 1.72e-03 | 21 | 215 | 3 | 3.30.230.10 | |
| Domain | HISTONE_H2A | 1.72e-03 | 21 | 215 | 3 | PS00046 | |
| Domain | PDZ | 1.85e-03 | 151 | 215 | 7 | PS50106 | |
| Domain | EF-hand-dom_pair | 1.87e-03 | 287 | 215 | 10 | IPR011992 | |
| Domain | - | 1.92e-03 | 6 | 215 | 2 | 3.90.1290.10 | |
| Domain | FAD_binding_1 | 1.92e-03 | 6 | 215 | 2 | PF00667 | |
| Domain | - | 1.92e-03 | 6 | 215 | 2 | 1.20.990.10 | |
| Domain | FAD-binding_1 | 1.92e-03 | 6 | 215 | 2 | IPR003097 | |
| Domain | NADPH_Cyt_P450_Rdtase_dom3 | 1.92e-03 | 6 | 215 | 2 | IPR023173 | |
| Domain | PDZ | 1.92e-03 | 152 | 215 | 7 | IPR001478 | |
| Domain | Ribosomal_S5_D2-typ_fold_subgr | 1.97e-03 | 22 | 215 | 3 | IPR014721 | |
| Domain | - | 2.24e-03 | 48 | 215 | 4 | 2.60.120.10 | |
| Domain | Spectrin | 2.25e-03 | 23 | 215 | 3 | PF00435 | |
| Domain | Histone_H2A | 2.25e-03 | 23 | 215 | 3 | IPR002119 | |
| Domain | H2A | 2.25e-03 | 23 | 215 | 3 | SM00414 | |
| Domain | EF_HAND_1 | 2.56e-03 | 204 | 215 | 8 | PS00018 | |
| Domain | Vinculin/catenin | 2.67e-03 | 7 | 215 | 2 | IPR006077 | |
| Domain | Plectin | 2.67e-03 | 7 | 215 | 2 | PF00681 | |
| Domain | Plectin_repeat | 2.67e-03 | 7 | 215 | 2 | IPR001101 | |
| Domain | PLEC | 2.67e-03 | 7 | 215 | 2 | SM00250 | |
| Domain | RmlC-like_jellyroll | 2.79e-03 | 51 | 215 | 4 | IPR014710 | |
| Domain | Integrin_dom | 2.87e-03 | 25 | 215 | 3 | IPR032695 | |
| Domain | AAA | 3.00e-03 | 52 | 215 | 4 | PF00004 | |
| Domain | ATPase_AAA_core | 3.44e-03 | 54 | 215 | 4 | IPR003959 | |
| Domain | Flavodoxin/NO_synth | 3.53e-03 | 8 | 215 | 2 | IPR008254 | |
| Domain | Flavdoxin-like | 3.53e-03 | 8 | 215 | 2 | IPR001094 | |
| Domain | FLAVODOXIN_LIKE | 3.53e-03 | 8 | 215 | 2 | PS50902 | |
| Domain | Flavodoxin_1 | 3.53e-03 | 8 | 215 | 2 | PF00258 | |
| Domain | A2M_N_2 | 3.53e-03 | 8 | 215 | 2 | SM01359 | |
| Domain | - | 3.53e-03 | 8 | 215 | 2 | 2.60.40.690 | |
| Domain | A2M_recep | 3.53e-03 | 8 | 215 | 2 | SM01361 | |
| Domain | A2M | 3.53e-03 | 8 | 215 | 2 | SM01360 | |
| Domain | LRR_6 | 3.68e-03 | 55 | 215 | 4 | PF13516 | |
| Domain | ATPase_AAA_CS | 4.41e-03 | 29 | 215 | 3 | IPR003960 | |
| Domain | Spectrin_repeat | 4.41e-03 | 29 | 215 | 3 | IPR002017 | |
| Domain | IQ | 4.42e-03 | 93 | 215 | 5 | PS50096 | |
| Domain | Drf_GBD | 4.50e-03 | 9 | 215 | 2 | PF06371 | |
| Domain | Drf_FH3 | 4.50e-03 | 9 | 215 | 2 | PF06367 | |
| Domain | FH3_dom | 4.50e-03 | 9 | 215 | 2 | IPR010472 | |
| Domain | GTPase-bd | 4.50e-03 | 9 | 215 | 2 | IPR010473 | |
| Domain | Drf_FH3 | 4.50e-03 | 9 | 215 | 2 | SM01139 | |
| Domain | Drf_GBD | 4.50e-03 | 9 | 215 | 2 | SM01140 | |
| Domain | A2M | 5.59e-03 | 10 | 215 | 2 | PF00207 | |
| Domain | A2M_N_2 | 5.59e-03 | 10 | 215 | 2 | IPR011625 | |
| Pathway | REACTOME_TIGHT_JUNCTION_INTERACTIONS | 3.18e-05 | 6 | 167 | 3 | MM15065 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | MYH11 CKAP5 SOWAHC IQGAP1 ARHGAP22 DST RHOBTB1 PARD6A DIAPH2 KIF5B IQGAP3 GOLGA3 PKN3 RANGAP1 RAP1GDS1 FMNL3 CDC37 ARHGAP5 CSK H2AX CTNNA1 PEAK1 | 4.15e-05 | 720 | 167 | 22 | M41838 |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 6.56e-05 | 85 | 167 | 7 | M16441 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | MYH11 CKAP5 SOWAHC IQGAP1 ARHGAP22 DST RHOBTB1 PARD6A DIAPH2 KIF5B IQGAP3 GOLGA3 PKN3 RANGAP1 FMNL3 CDC37 ARHGAP5 CSK CTNNA1 PEAK1 | 8.49e-05 | 649 | 167 | 20 | MM15690 |
| Pathway | REACTOME_G1_S_DNA_DAMAGE_CHECKPOINTS | 1.07e-04 | 64 | 167 | 6 | MM15386 | |
| Pathway | BIOCARTA_CELL2CELL_PATHWAY | 1.30e-04 | 9 | 167 | 3 | MM1366 | |
| Pathway | REACTOME_G1_S_DNA_DAMAGE_CHECKPOINTS | 1.51e-04 | 68 | 167 | 6 | M27672 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 1.53e-04 | 165 | 167 | 9 | MM15026 | |
| Pathway | KEGG_TIGHT_JUNCTION | 1.74e-04 | 132 | 167 | 8 | M11355 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | SOWAHC IQGAP1 ARHGAP22 DST RHOBTB1 PARD6A DIAPH2 IQGAP3 GOLGA3 PKN3 FMNL3 CDC37 ARHGAP5 CSK PEAK1 | 2.30e-04 | 439 | 167 | 15 | MM15595 |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 2.51e-04 | 11 | 167 | 3 | M22027 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 2.78e-04 | 76 | 167 | 6 | MM14867 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | SOWAHC IQGAP1 ARHGAP22 DST RHOBTB1 PARD6A DIAPH2 IQGAP3 GOLGA3 PKN3 FMNL3 CDC37 ARHGAP5 CSK PEAK1 | 2.99e-04 | 450 | 167 | 15 | M27078 |
| Pathway | REACTOME_G2_M_CHECKPOINTS | 3.01e-04 | 143 | 167 | 8 | MM15383 | |
| Pathway | REACTOME_UBIQUITIN_MEDIATED_DEGRADATION_OF_PHOSPHORYLATED_CDC25A | 3.03e-04 | 50 | 167 | 5 | MM15385 | |
| Pathway | BIOCARTA_CELL2CELL_PATHWAY | 3.32e-04 | 12 | 167 | 3 | M12851 | |
| Pathway | REACTOME_REGULATION_OF_RUNX3_EXPRESSION_AND_ACTIVITY | 3.64e-04 | 52 | 167 | 5 | MM15536 | |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | PSMA7 CKAP5 PSMC1 PSMC3 PSMC6 MDM2 RMI1 RANGAP1 HUS1 H2AX CDC25A | 3.87e-04 | 271 | 167 | 11 | MM15388 |
| Pathway | WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR | 3.94e-04 | 81 | 167 | 6 | M39490 | |
| Pathway | REACTOME_STABILIZATION_OF_P53 | 4.35e-04 | 54 | 167 | 5 | MM15384 | |
| Pathway | REACTOME_DEGRADATION_OF_DVL | 4.74e-04 | 55 | 167 | 5 | MM15153 | |
| Pathway | REACTOME_REGULATION_OF_RUNX3_EXPRESSION_AND_ACTIVITY | 4.74e-04 | 55 | 167 | 5 | M27809 | |
| Pathway | REACTOME_CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY | 5.10e-04 | 85 | 167 | 6 | M27674 | |
| Pathway | WP_PROTEASOME_DEGRADATION | 5.15e-04 | 56 | 167 | 5 | MM15901 | |
| Pathway | REACTOME_DEGRADATION_OF_DVL | 5.59e-04 | 57 | 167 | 5 | M27399 | |
| Pathway | REACTOME_STABILIZATION_OF_P53 | 5.59e-04 | 57 | 167 | 5 | M27670 | |
| Pathway | REACTOME_UCH_PROTEINASES | 5.78e-04 | 87 | 167 | 6 | MM15287 | |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | PSMA7 CKAP5 PSMC1 PSMC3 PSMC6 MDM2 RMI1 RANGAP1 HUS1 H2AX CDC25A | 7.01e-04 | 291 | 167 | 11 | M16647 |
| Pathway | REACTOME_ASYMMETRIC_LOCALIZATION_OF_PCP_PROTEINS | 7.09e-04 | 60 | 167 | 5 | MM15150 | |
| Pathway | WP_PROTEASOME_DEGRADATION | 8.25e-04 | 62 | 167 | 5 | M39639 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION | 8.33e-04 | 36 | 167 | 4 | M47758 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION | 8.33e-04 | 36 | 167 | 4 | M47713 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION | 8.33e-04 | 36 | 167 | 4 | M47714 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION | 8.33e-04 | 36 | 167 | 4 | M47702 | |
| Pathway | REACTOME_G2_M_CHECKPOINTS | 8.43e-04 | 167 | 167 | 8 | M19381 | |
| Pathway | REACTOME_MITOTIC_G1_PHASE_AND_G1_S_TRANSITION | 9.00e-04 | 130 | 167 | 7 | MM15146 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 9.00e-04 | 300 | 167 | 11 | M610 | |
| Pathway | REACTOME_RHOV_GTPASE_CYCLE | 9.25e-04 | 37 | 167 | 4 | M41819 | |
| Pathway | REACTOME_RHOV_GTPASE_CYCLE | 9.25e-04 | 37 | 167 | 4 | MM15610 | |
| Pathway | REACTOME_ASYMMETRIC_LOCALIZATION_OF_PCP_PROTEINS | 9.53e-04 | 64 | 167 | 5 | M27396 | |
| Pathway | REACTOME_CELL_CELL_COMMUNICATION | 9.72e-04 | 96 | 167 | 6 | MM14592 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY | 9.83e-04 | 17 | 167 | 3 | MM15561 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | MYH11 CKAP5 IQGAP1 DIAPH2 KIF5B IQGAP3 PKN3 RANGAP1 FMNL3 CTNNA1 | 9.83e-04 | 257 | 167 | 10 | MM14755 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.01e-03 | 258 | 167 | 10 | MM14572 | |
| Pathway | KEGG_MEDICUS_REFERENCE_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION | 1.13e-03 | 39 | 167 | 4 | M47701 | |
| Pathway | REACTOME_RHOU_GTPASE_CYCLE | 1.13e-03 | 39 | 167 | 4 | MM15607 | |
| Pathway | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | 1.14e-03 | 99 | 167 | 6 | MM14986 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | A2M ABCA1 MYO5B ATP8A2 PSMA7 PSMC1 PSMC3 PSMC6 ABCA9 SCNN1B ABCC1 RIPK3 SLC39A3 CASQ1 ATP8B2 LPA ATP6V0A4 MTTP ATP2B1 | 1.15e-03 | 736 | 167 | 19 | M27287 |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 1.17e-03 | 18 | 167 | 3 | MM1549 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | A2M ABCA1 MYO5B ATP8A2 PSMA7 PSMC1 PSMC3 PSMC6 ABCA9 SCNN1B ABCC1 RIPK3 SLC39A3 CASQ1 ATP8B2 ATP6V0A4 MTTP ATP2B1 | 1.20e-03 | 681 | 167 | 18 | MM14985 |
| Pathway | REACTOME_RHOU_GTPASE_CYCLE | 1.25e-03 | 40 | 167 | 4 | M41816 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_UBQLN2_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION | 1.25e-03 | 40 | 167 | 4 | M47749 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_VCP_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION | 1.25e-03 | 40 | 167 | 4 | M47748 | |
| Pathway | REACTOME_UCH_PROTEINASES | 1.33e-03 | 102 | 167 | 6 | M27576 | |
| Pathway | REACTOME_DISEASES_OF_MISMATCH_REPAIR_MMR | 1.36e-03 | 5 | 167 | 2 | M27448 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION | 1.37e-03 | 41 | 167 | 4 | M47747 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY | 1.38e-03 | 19 | 167 | 3 | M27841 | |
| Pathway | REACTOME_PHASE_4_RESTING_MEMBRANE_POTENTIAL | 1.38e-03 | 19 | 167 | 3 | MM15194 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 1.40e-03 | 103 | 167 | 6 | MM15196 | |
| Pathway | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | 1.40e-03 | 103 | 167 | 6 | M758 | |
| Pathway | REACTOME_RHOC_GTPASE_CYCLE | 1.43e-03 | 70 | 167 | 5 | MM15597 | |
| Pathway | REACTOME_CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY | 1.43e-03 | 70 | 167 | 5 | MM15389 | |
| Pathway | REACTOME_G1_S_TRANSITION | 1.47e-03 | 104 | 167 | 6 | MM15376 | |
| Pathway | REACTOME_CELL_CYCLE | PSMA7 CKAP5 PSMC1 PSMC3 PSMC6 MDM2 RMI1 SYCP1 MLH1 RANGAP1 HUS1 POLA1 SYNE1 NUMA1 TFDP1 NINL H2AX CDC25A | 1.48e-03 | 694 | 167 | 18 | M543 |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 1.51e-03 | 142 | 167 | 7 | MM15576 | |
| Pathway | WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY | 1.62e-03 | 106 | 167 | 6 | M42535 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | MYH11 CKAP5 IQGAP1 DIAPH2 KIF5B IQGAP3 PKN3 RANGAP1 FMNL3 H2AX CTNNA1 | 1.63e-03 | 323 | 167 | 11 | M27080 |
| Pathway | REACTOME_CELL_JUNCTION_ORGANIZATION | 1.72e-03 | 73 | 167 | 5 | MM15126 | |
| Pathway | REACTOME_RHOC_GTPASE_CYCLE | 1.83e-03 | 74 | 167 | 5 | M41807 | |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 1.98e-03 | 149 | 167 | 7 | M41805 | |
| Pathway | REACTOME_MITOTIC_G1_PHASE_AND_G1_S_TRANSITION | 1.98e-03 | 149 | 167 | 7 | M848 | |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | 1.99e-03 | 191 | 167 | 8 | MM15289 | |
| Pathway | REACTOME_LDL_REMODELING | 2.03e-03 | 6 | 167 | 2 | M42520 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3 | 2.06e-03 | 76 | 167 | 5 | MM15520 | |
| Pathway | KEGG_PROTEASOME | 2.10e-03 | 46 | 167 | 4 | M10680 | |
| Pathway | BIOCARTA_G2_PATHWAY | 2.13e-03 | 22 | 167 | 3 | MM1365 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 2.28e-03 | 47 | 167 | 4 | MM14925 | |
| Pathway | REACTOME_ABC_TRANSPORTER_DISORDERS | 2.31e-03 | 78 | 167 | 5 | M27473 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | EPPK1 ERC1 ESD PSMA7 CKAP5 PSMC1 PSMC3 NASP PSMC6 PFAS IQGAP1 EIF3CL DST MDN1 UGP2 KIF5B IQGAP3 PLS3 KIF11 FKBP10 RANGAP1 BAG5 LZTFL1 BAG3 FARSB CCT4 LCP1 PDIA4 CDC37 LUC7L2 PDCD5 NEMF | 2.86e-12 | 1149 | 222 | 32 | 35446349 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | PSMA7 CKAP5 PSMC1 PSMC3 NASP PSMC6 PFAS IQGAP1 EIF3CL CDCA2 MDN1 SUPV3L1 KIF5B IQGAP3 PLS3 KIF11 RANGAP1 MTHFD1L POLA1 SYNE1 PCLO NUMA1 POR FARSB H2AC21 CCT4 MSH3 PDIA4 CDC37 LUC7L2 NEMF CCAR1 PEAK1 GFM1 ATP2B1 | 8.34e-12 | 1425 | 222 | 35 | 30948266 |
| Pubmed | MYH11 MYO5B ERC1 PSMA7 FKBP9 CKAP5 PSMC1 PSMC3 ITGA2 ACTN3 IQGAP1 EIF3CL DST SACS UGP2 KIF5B ST13P5 NOS1 PLS3 GOLGA3 KRT78 RAP1GDS1 SYNE1 PCLO POR FARSB CCT4 SHROOM2 ARHGAP5 GUCY1A2 SUGP2 CTNNA1 PEAK1 PLCH1 ATP2B1 | 9.37e-12 | 1431 | 222 | 35 | 37142655 | |
| Pubmed | EPPK1 PSMA7 CKAP5 PSMC1 PSMC3 NASP PSMC6 SRPRA IQGAP1 MDN1 KIF5B NELFB POR CCT4 CDC37 LUC7L2 PDCD5 CTNNA1 ATP2B1 | 1.51e-11 | 399 | 222 | 19 | 37536630 | |
| Pubmed | MYH11 MYO5B ERC1 PSMA7 ACTN3 IQGAP1 CDCA2 BNIP1 DST BBX MDN1 SACS SYCP1 UGP2 KDR KIF5B KIF11 DOC2A RANGAP1 SYNE1 PCLO NUMA1 H2AC21 CCT4 LCP1 PDIA4 GUCY1A2 H2AC1 MTTP CCAR1 H2AX MYH15 PLCH1 ATP2B1 | 5.12e-11 | 1442 | 222 | 34 | 35575683 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | A2M CNNM2 CTNNAL1 CKAP5 PSMC1 PSMC3 PSMC6 PFAS SRPRA PLS3 KIF11 FKBP10 MTHFD1L BAG3 OBSL1 FARSB CCT4 LCP1 SIL1 PDIA4 CDC37 CSK GHITM CTNNA1 CDC25A GFM1 ATP2B1 | 1.85e-10 | 974 | 222 | 27 | 28675297 |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | DCAKD CNNM2 MYO5B ERC1 MDN1 GCC1 GOLGA3 FKBP10 ABCC1 RAP1GDS1 POLA1 BAG5 BAG3 POR SIL1 PDIA4 SUGP2 GCC2 MTIF2 GHITM NINL CCAR1 ATP2B1 | 7.39e-10 | 754 | 222 | 23 | 33060197 |
| Pubmed | TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | CKAP5 NASP PFAS RNF40 IQGAP1 EIF3CL KIF5B PLS3 KIF11 COL6A3 MTHFD1L PDIA4 | 2.06e-09 | 179 | 222 | 12 | 36261009 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | EPPK1 ECHDC1 PSMC1 PSMC3 PSMC6 PFAS IQGAP1 KIF5B IQGAP3 KIF11 RANGAP1 MTHFD1L POLA1 NUMA1 NELFB FARSB CCT4 MSH3 CDC37 SUGP2 CCAR1 | 6.22e-09 | 704 | 222 | 21 | 29955894 |
| Pubmed | CTNNAL1 ERC1 CKAP5 PSMC1 SRPRA IQGAP1 DST KIF5B PLS3 RANGAP1 HDAC6 NUMA1 FARSB CCT4 PDIA4 CSK CTNNA1 PEAK1 PLCH1 PARD3 ATP2B1 | 6.87e-09 | 708 | 222 | 21 | 39231216 | |
| Pubmed | Mdm2 facilitates the association of p53 with the proteasome. | 7.74e-09 | 12 | 222 | 5 | 20479273 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | PSMA7 CKAP5 PSMC1 PSMC3 PSMC6 PFAS IQGAP1 CDCA2 DST MDN1 SUPV3L1 MLH1 KIF5B KIF11 RANGAP1 HDAC6 MTHFD1L POLA1 BAG3 NUMA1 FARSB CCT4 MSH3 CDC37 SUGP2 CCAR1 GSDMA PARD3 ATP2B1 | 1.29e-08 | 1353 | 222 | 29 | 29467282 |
| Pubmed | ERC1 IQGAP1 DST MLH1 KIF5B MAP4K2 GOLGA3 ATPAF1 NUMA1 MSH3 SIL1 CDC37 PDCD5 CCAR1 CTNNA1 | 1.34e-08 | 360 | 222 | 15 | 33111431 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | A2M EPPK1 PSMA7 CKAP5 PSMC1 NASP PSMC6 PFAS ITGAM IQGAP1 SUPV3L1 UGP2 KIF5B KIF11 FKBP10 RANGAP1 KRT78 RAP1GDS1 HDAC6 MTHFD1L BAG3 CCT4 IFIT1 PDIA4 CDC37 LUC7L CCAR1 GSDMA CTNNA1 | 1.62e-08 | 1367 | 222 | 29 | 32687490 |
| Pubmed | EPPK1 CKAP5 PSMC1 PSMC3 PSMC6 SRPRA RNF40 KIF5B KIF11 POR CCT4 CCAR1 GSDMA ATP2B1 | 2.25e-08 | 320 | 222 | 14 | 28685749 | |
| Pubmed | Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase. | PSMA7 CKAP5 PSMC1 PSMC3 NASP PSMC6 IQGAP1 EIF3CL RHOBTB1 PLS3 KIF11 RANGAP1 HDAC6 BAG3 CCT4 PDIA4 CDC37 | 2.45e-08 | 495 | 222 | 17 | 28581483 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | DCAKD ZNF143 MYO5B ERC1 ECHDC1 PSMA7 PSMC3 PSMC6 TUFT1 IQGAP1 EIF3CL BNIP1 FAM117A BBX CNOT7 IQGAP3 PLS3 PKN3 IFT20 LZTFL1 BAG3 OBSL1 PCARE WDR19 GCC2 NINL CTNNA1 PARD3 | 2.98e-08 | 1321 | 222 | 28 | 27173435 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | THNSL1 PSMA7 PSMC1 PSMC3 PSMC6 SRPRA BNIP1 DST MDN1 SUPV3L1 GTPBP3 GOLGA3 ATPAF1 MTHFD1L SYNE1 PCLO BAG5 OBSL1 POR CCT4 IFIT1 PDIA4 CDC37 LUC7L H2AC1 LUC7L2 MTIF2 PDCD5 GHITM GFM1 | 3.13e-08 | 1496 | 222 | 30 | 32877691 |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | EPPK1 CKAP5 PSMC1 PSMC3 IQGAP1 MDN1 KIF5B KIF11 RANGAP1 POLA1 NUMA1 FARSB CCT4 MSH3 | 3.56e-08 | 332 | 222 | 14 | 32786267 |
| Pubmed | METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis. | PSMA7 CKAP5 PSMC1 NASP PSMC6 EIF3CL KIF5B ST13P5 COL6A3 MTHFD1L H2AC1 H2AX | 3.59e-08 | 231 | 222 | 12 | 36597993 |
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | CNNM2 CKAP5 PSMC3 CDCA2 SYNE1 BAG5 H2AC21 CASQ1 CCT4 C16orf96 PDIA4 CDC37 CSK PDCD5 PEAK1 PARD3 CDC25A ATP2B1 | 3.64e-08 | 573 | 222 | 18 | 28330616 |
| Pubmed | A2M ZNF143 THNSL1 SREBF2 PFAS SRPRA DST SUPV3L1 DIAPH2 MLH1 IQGAP3 SAMD4B OBSL1 FHIP2A LUC7L2 MTIF2 NEMF CCAR1 PLCH1 | 4.66e-08 | 650 | 222 | 19 | 38777146 | |
| Pubmed | ERC1 CKAP5 PSMC1 NASP RNF40 CNOT8 IQGAP1 TRIM66 DST SACS SUPV3L1 NAV3 GOLGA3 RAP1GDS1 HDAC6 SYNE1 OBSL1 CRTAC1 MSH3 SHROOM2 WDR19 ARHGAP5 MTIF2 NEMF CCAR1 ZNF76 CTNNA1 | 6.42e-08 | 1285 | 222 | 27 | 35914814 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | CKAP5 PSMC1 PSMC3 NASP PSMC6 PFAS ACTN3 IQGAP1 EIF3CL RANGAP1 MTHFD1L BAG3 FARSB H2AC21 CCT4 LUC7L LUC7L2 CCAR1 H2AX | 6.65e-08 | 665 | 222 | 19 | 30457570 |
| Pubmed | A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. | DCAKD ERC1 MDN1 GCC1 GOLGA3 FKBP10 RAP1GDS1 POLA1 POR SIL1 GCC2 GHITM NINL | 7.48e-08 | 298 | 222 | 13 | 32353859 |
| Pubmed | DCAKD CTNNAL1 MYO5B ERC1 PSMC1 PSMC3 PSMC6 PFAS SRPRA CDCA2 MLH1 ABCC1 RANGAP1 BAG5 BAG3 POR CCT4 PDIA4 ARHGAP5 CSK CTNNA1 PEAK1 CDC25A ATP2B1 | 7.80e-08 | 1049 | 222 | 24 | 27880917 | |
| Pubmed | PSMA7 PFAS SRPRA BNIP1 MDN1 SACS PLS3 GOLGA3 ATPAF1 FKBP10 RANGAP1 MTHFD1L SYNE1 BAG5 BAG3 OBSL1 POR TRAPPC8 TFDP1 WDR19 PDIA4 CDC37 MTIF2 GHITM CTNNA1 PEAK1 PLCH1 PARD3 ATP2B1 | 9.80e-08 | 1487 | 222 | 29 | 33957083 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | MYH11 ERC1 PSMA7 CKAP5 PSMC1 PSMC3 NASP PSMC6 RNF40 MDN1 KIF5B ST13P5 PLS3 RANGAP1 NUMA1 CCT4 LCP1 PDIA4 LUC7L2 PDCD5 ATP2B1 | 1.43e-07 | 847 | 222 | 21 | 35235311 |
| Pubmed | ERC1 ECHDC1 PSMA7 CKAP5 KIF5B PLS3 GOLGA3 KIF11 RANGAP1 BAG3 PDCD5 | 1.65e-07 | 216 | 222 | 11 | 31519766 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | DCAKD MYH11 ERC1 SREBF2 PSMC1 PSMC3 PSMC6 SRPRA IQGAP1 BNIP1 KIF5B IQGAP3 KIF11 FKBP10 ABCC1 RANGAP1 BAG3 OBSL1 POR FARSB PDIA4 CTNNA1 | 1.98e-07 | 942 | 222 | 22 | 31073040 |
| Pubmed | Control of a neuronal morphology program by an RNA-binding zinc finger protein, Unkempt. | CKAP5 CNOT8 DST UGP2 MLLT6 PLS3 CCT4 TRAPPC8 ARHGAP5 GHITM CTNNA1 ATP2B1 | 2.04e-07 | 271 | 222 | 12 | 25737280 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | PSMA7 FKBP9 PSMC1 PSMC3 NASP PSMC6 PFAS IQGAP1 EIF3CL UGP2 KIF5B PLS3 FKBP10 RANGAP1 RAP1GDS1 POLA1 BAG5 LZTFL1 BAG3 NELFB FARSB CCT4 PDIA4 CDC37 TKFC LUC7L2 NCOA7 CTNNA1 | 2.18e-07 | 1455 | 222 | 28 | 22863883 |
| Pubmed | EPPK1 CKAP5 PSMC3 PFAS IQGAP1 DST MDN1 KIF5B RANGAP1 MTHFD1L POLA1 NUMA1 LCP1 PDIA4 SUGP2 CCAR1 H2AX CTNNA1 | 2.52e-07 | 653 | 222 | 18 | 22586326 | |
| Pubmed | 2.57e-07 | 3 | 222 | 3 | 27841945 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | MYH11 EPPK1 ERC1 ESD PSMA7 PSMC3 CLSTN2 IQGAP1 DST MDN1 IQGAP3 SYNE1 PCLO NUMA1 CCT4 PDIA4 CDC37 H2AC1 CTNNA1 PEAK1 | 2.90e-07 | 807 | 222 | 20 | 30575818 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | EPPK1 ERC1 PSMA7 CKAP5 PSMC1 PSMC3 PFAS SRPRA RNF40 IQGAP1 KIF5B PLS3 KIF11 RANGAP1 HDAC6 MTHFD1L POLA1 BAG5 BAG3 NUMA1 NELFB FARSB CCT4 LUC7L LUC7L2 NEMF CTNNA1 | 4.31e-07 | 1415 | 222 | 27 | 28515276 |
| Pubmed | A2M STK36 EPPK1 ERC1 SLC6A17 PSMC1 PSMC3 NASP PFAS RNF40 RHOBTB1 GOLGA3 ABCC1 RIPK3 MTHFD1L SYNE1 IFIT1 CARD8 H2AC1 | 4.53e-07 | 754 | 222 | 19 | 35906200 | |
| Pubmed | CNNM2 THNSL1 ARHGAP22 RHOBTB1 SUPV3L1 DCLRE1A KIF5B KIF11 BAG3 CRTAC1 IFIT1 GHITM CCAR1 PARD3 | 5.38e-07 | 415 | 222 | 14 | 16385451 | |
| Pubmed | ERC1 PSMA7 CKAP5 PSMC1 PSMC3 PSMC6 IQGAP1 KIF5B KIF11 RANGAP1 NUMA1 CCT4 PDIA4 CDC37 CTNNA1 | 7.90e-07 | 494 | 222 | 15 | 26831064 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ERC1 CKAP5 CDCA2 FAM117A DST MDN1 KIF5B KIF11 KRT78 SAMD4B BAG3 NELFB CARD8 LUC7L MAP4K1 NCOA7 PEAK1 PLCH1 PARD3 ATP2B1 | 7.93e-07 | 861 | 222 | 20 | 36931259 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | EPPK1 MYO5B CKAP5 PSMC1 IQGAP1 DST MDN1 SACS KIF5B RANGAP1 KRT78 SYNE1 NUMA1 OBSL1 H2AC21 CCT4 PDIA4 LUC7L SUGP2 H2AC1 CTNNA1 ATP2B1 | 8.01e-07 | 1024 | 222 | 22 | 24711643 |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | STK36 EPPK1 ERC1 PSMA7 PSMC1 PSMC3 NASP PSMC6 PFAS CNOT8 IQGAP1 UGP2 KIF5B PLS3 RANGAP1 KRT78 HUS1 MTHFD1L SAMD4B NELFB PDIA4 CDC37 LUC7L LUC7L2 PARD3 | 8.30e-07 | 1284 | 222 | 25 | 17353931 |
| Pubmed | ERC1 ESD PSMC1 PFAS IQGAP1 KIF5B GOLGA3 OBSL1 FARSB TRAPPC8 CDC37 LUC7L2 CCAR1 NCOA7 | 9.92e-07 | 437 | 222 | 14 | 20562859 | |
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | A2M PSMA7 PSMC1 NASP CNOT8 CDCA2 RMI1 CNOT7 KDR KIF5B MAP4K2 HDAC6 RETREG2 NELFB POR CCT4 PDIA4 CDC37 LUC7L2 PDCD5 H2AX CTNNA1 CDC25A | 1.02e-06 | 1124 | 222 | 23 | 21900206 |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | A2M MYH11 EPPK1 PSMA7 PSMC3 PSMC6 ITGA2 ACTN3 MDN1 IQGAP3 BAG3 CCT4 PDIA4 CDC37 GSDMA CTNNA1 ATP2B1 | 1.06e-06 | 647 | 222 | 17 | 26618866 |
| Pubmed | A distinct PAR complex associates physically with VE-cadherin in vertebrate endothelial cells. | 1.10e-06 | 13 | 222 | 4 | 17057644 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | EPPK1 CKAP5 PSMC1 PSMC3 PSMC6 IQGAP1 MDN1 SUPV3L1 MLH1 KIF11 RANGAP1 CCT4 LUC7L CSK LUC7L2 CTNNA1 | 1.24e-06 | 582 | 222 | 16 | 20467437 |
| Pubmed | 1.54e-06 | 14 | 222 | 4 | 34026442 | ||
| Pubmed | AMBRA1 interplay with cullin E3 ubiquitin ligases regulates autophagy dynamics. | 1.94e-06 | 58 | 222 | 6 | 25499913 | |
| Pubmed | DCAKD PSMA7 PSMC1 PSMC3 PSMC6 SRPRA IQGAP1 BNIP1 DST MDN1 CNOT7 PLS3 ABCC1 RANGAP1 MTHFD1L BAG5 NUMA1 FARSB CCT4 FHIP2A IFIT1 CDC37 LUC7L LUC7L2 CTNNA1 ATP2B1 | 1.99e-06 | 1440 | 222 | 26 | 30833792 | |
| Pubmed | ESD PSMA7 CKAP5 PSMC1 PSMC3 PSMC6 PFAS SUPV3L1 MTHFD1L FARSB POLR3C PDIA4 CDC37 GFM1 ATP2B1 | 2.06e-06 | 534 | 222 | 15 | 35032548 | |
| Pubmed | Cdx2 regulates endo-lysosomal function and epithelial cell polarity. | 2.08e-06 | 33 | 222 | 5 | 20551175 | |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | A2M EPPK1 ESD PSMC3 PFAS IQGAP1 KIF5B MTHFD1L BAG3 NUMA1 FARSB LCP1 PDIA4 LUC7L2 CTNNA1 GFM1 | 2.13e-06 | 607 | 222 | 16 | 39147351 |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | CKAP5 PFAS ITGAM IQGAP1 EIF3CL MDN1 KIF5B MTHFD1L CCT4 LCP1 PDIA4 H2AX | 2.51e-06 | 344 | 222 | 12 | 30333137 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | CKAP5 NASP IQGAP1 EIF3CL MDN1 RANGAP1 HDAC6 NELFA SAMD4B BAG3 NUMA1 NELFB SUGP2 MAP4K1 PDCD5 CCAR1 CTNNA1 PARD3 | 2.84e-06 | 774 | 222 | 18 | 15302935 |
| Pubmed | CTNNAL1 PARD6G ITGA2 DST PARD6A GOLGA3 ABCC1 ARHGAP5 CTNNA1 PEAK1 PLCH1 PARD3 ATP2B1 | 3.63e-06 | 421 | 222 | 13 | 36976175 | |
| Pubmed | CKAP5 PSMC1 PSMC3 PSMC6 IQGAP1 MDN1 PLS3 KIF11 RANGAP1 POLA1 BAG5 NELFB CCT4 CDC37 SUGP2 CCAR1 | 4.01e-06 | 638 | 222 | 16 | 33239621 | |
| Pubmed | STK36 MYH11 HECW1 MYO5B PFAS CTIF TRIM66 RHOBTB1 SACS NELFB TRAPPC8 ATP8B2 PEAK1 PLCH1 | 4.02e-06 | 493 | 222 | 14 | 15368895 | |
| Pubmed | ECHDC1 PSMC1 NASP IQGAP1 PLS3 ABCC1 RANGAP1 RAP1GDS1 LZTFL1 H2AC21 CCT4 PDIA4 CDC37 TKFC CSK H2AC1 H2AX CTNNA1 ATP2B1 | 4.21e-06 | 878 | 222 | 19 | 37223481 | |
| Pubmed | HECW1 ERC1 CKAP5 JAKMIP2 IQGAP1 DST MDN1 DIAPH2 KIF5B NOS1 GOLGA3 KIF11 RANGAP1 SYNE1 NUMA1 FARSB CCT4 CCAR1 CTNNA1 PARD3 | 4.30e-06 | 963 | 222 | 20 | 28671696 | |
| Pubmed | A2M PSMA7 CROCC2 GOLGA3 PCLO OBSL1 H2AC21 MSH3 CDC37 GCC2 ATP6V0A4 NEMF USP40 CTNNA1 | 4.31e-06 | 496 | 222 | 14 | 31343991 | |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | ESD SLC6A17 PSMC1 PSMC6 BNIP1 MAP4K2 KIF11 ABCC1 NELFA SYNE1 BAG5 TRAPPC8 GHITM NCOA7 PEAK1 PARD3 ATP2B1 | 4.34e-06 | 719 | 222 | 17 | 35337019 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | NASP PSMC6 SRPRA MDN1 CROCC2 DIAPH2 MTHFD1L NUMA1 PCDHB9 LCP1 KMO LUC7L2 CCAR1 CTNNA1 | 4.41e-06 | 497 | 222 | 14 | 36774506 |
| Pubmed | HECW1 ERC1 CKAP5 PSMC1 SRPRA EIF3CL NAV3 KIF5B ST13P5 NOS1 RANGAP1 RETREG2 PCLO LZTFL1 POR CCT4 SHROOM2 SUGP2 PDCD5 H2AX PEAK1 GFM1 | 4.48e-06 | 1139 | 222 | 22 | 36417873 | |
| Pubmed | Meiosis I progression in spermatogenesis requires a type of testis-specific 20S core proteasome. | 4.61e-06 | 18 | 222 | 4 | 31358751 | |
| Pubmed | Cdc42 controls progenitor cell differentiation and beta-catenin turnover in skin. | 4.89e-06 | 39 | 222 | 5 | 16510873 | |
| Pubmed | Chromosomal localization and immunological analysis of a family of human 26S proteasomal ATPases. | 5.06e-06 | 6 | 222 | 3 | 9473509 | |
| Pubmed | 5.06e-06 | 6 | 222 | 3 | 23269666 | ||
| Pubmed | Pold3 is required for genomic stability and telomere integrity in embryonic stem cells and meiosis. | 5.06e-06 | 6 | 222 | 3 | 29447390 | |
| Pubmed | 5.06e-06 | 6 | 222 | 3 | 14718566 | ||
| Pubmed | PSMA7 PSMC1 PSMC3 PSMC6 AKAP4 DST UGP2 SYNE1 BAG5 H2AC21 TKFC H2AC1 H2AX | 5.57e-06 | 438 | 222 | 13 | 21630459 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | CKAP5 TUFT1 CNOT8 IQGAP1 EIF3CL RMI1 PARD6A CNOT7 SYCP1 IQGAP3 PLS3 RANGAP1 HDAC6 RETREG2 IFT20 SYNE1 NUMA1 PDIA4 CSK PDCD5 CCAR1 CTNNA1 | 5.58e-06 | 1155 | 222 | 22 | 20360068 |
| Pubmed | PAR3beta, a novel homologue of the cell polarity protein PAR3, localizes to tight junctions. | 8.81e-06 | 7 | 222 | 3 | 12459187 | |
| Pubmed | 8.81e-06 | 7 | 222 | 3 | 11361004 | ||
| Pubmed | Structure of the human 26S proteasome at a resolution of 3.9 Ã…. | 8.81e-06 | 7 | 222 | 3 | 27342858 | |
| Pubmed | DCAKD EPPK1 PSMA7 IQGAP1 EIF3CL DST SYCP1 UGP2 HDAC6 SYNE1 FARSB H2AC21 CCT4 CSK H2AC1 H2AX GSDMA CTNNA1 | 9.25e-06 | 844 | 222 | 18 | 25963833 | |
| Pubmed | Yeast two-hybrid screening identified WDR77 as a novel interacting partner of TSC22D2. | 1.01e-05 | 45 | 222 | 5 | 27337956 | |
| Pubmed | EPPK1 ERC1 PSMC1 PSMC3 NASP PSMC6 SRPRA SYNE1 BAG5 PDIA4 PDCD5 GFM1 ATP2B1 | 1.01e-05 | 463 | 222 | 13 | 34901782 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ERC1 ESD CKAP5 NASP PFAS DST MLH1 KIF5B PKN3 KIF11 RANGAP1 BAG3 NUMA1 FARSB CCT4 CDC37 SUGP2 PDCD5 NCOA7 | 1.01e-05 | 934 | 222 | 19 | 33916271 |
| Pubmed | 1.11e-05 | 78 | 222 | 6 | 27114451 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | DCAKD ZNF143 CKAP5 MDM2 BBX MDN1 KIF5B RANGAP1 HDAC6 OBSL1 FARSB MSH3 E4F1 TFDP1 SUGP2 GSDMA CDC25A ATP2B1 | 1.14e-05 | 857 | 222 | 18 | 25609649 |
| Pubmed | PSMA7 IQGAP1 KIF5B PLS3 RANGAP1 HDAC6 FARSB CCT4 IFIT1 POLR3C PDIA4 SUGP2 NEMF | 1.15e-05 | 469 | 222 | 13 | 37314180 | |
| Pubmed | C16orf72/HAPSTR1 is a molecular rheostat in an integrated network of stress response pathways. | 1.20e-05 | 119 | 222 | 7 | 35776542 | |
| Pubmed | 1.30e-05 | 23 | 222 | 4 | 36973253 | ||
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | A2M EPPK1 PSMA7 PFAS IQGAP1 DST PLS3 BAG3 NUMA1 FARSB CCT4 PDIA4 SUGP2 | 1.38e-05 | 477 | 222 | 13 | 31300519 |
| Pubmed | Association of ASIP/mPAR-3 with adherens junctions of mouse neuroepithelial cells. | 1.40e-05 | 8 | 222 | 3 | 12203721 | |
| Pubmed | Functions of the MRE11 complex in the development and maintenance of oocytes. | 1.40e-05 | 8 | 222 | 3 | 26232174 | |
| Pubmed | HDAC6 deacetylates and ubiquitinates MSH2 to maintain proper levels of MutSα. | 1.40e-05 | 8 | 222 | 3 | 24882211 | |
| Pubmed | Purification and characterization of 26S proteasomes from human and mouse spermatozoa. | 1.40e-05 | 8 | 222 | 3 | 9464850 | |
| Pubmed | 1.40e-05 | 8 | 222 | 3 | 11260256 | ||
| Pubmed | A mouse model for dominant collagen VI disorders: heterozygous deletion of Col6a3 Exon 16. | 1.40e-05 | 8 | 222 | 3 | 24563484 | |
| Pubmed | 1.60e-05 | 172 | 222 | 8 | 27375898 | ||
| Pubmed | A Large-scale genetic association study of esophageal adenocarcinoma risk. | 1.79e-05 | 351 | 222 | 11 | 20453000 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | ERC1 CKAP5 IQGAP1 DST KIF5B GOLGA3 RANGAP1 BAG3 CAPS ARHGAP5 CTNNA1 PEAK1 PARD3 ATP2B1 | 1.85e-05 | 565 | 222 | 14 | 25468996 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | ERC1 CKAP5 PSMC6 SRPRA CNOT8 DCLRE1A RANGAP1 KRT78 POLA1 C16orf96 POLR3C PDIA4 SUGP2 PDCD5 CCAR1 H2AX | 1.91e-05 | 724 | 222 | 16 | 36232890 |
| Pubmed | 1.96e-05 | 177 | 222 | 8 | 26485645 | ||
| Pubmed | ERC1 CKAP5 NASP SRPRA BNIP1 DST KIF5B RANGAP1 BAG3 NUMA1 POR TRAPPC8 GCC2 PDCD5 | 1.97e-05 | 568 | 222 | 14 | 37774976 | |
| Pubmed | Characterization of the interactome of the human MutL homologues MLH1, PMS1, and PMS2. | 2.07e-05 | 87 | 222 | 6 | 17148452 | |
| Pubmed | 2.10e-05 | 9 | 222 | 3 | 28031483 | ||
| Pubmed | 2.10e-05 | 9 | 222 | 3 | 18562307 | ||
| Interaction | DIRAS3 interactions | PSMC1 PSMC3 ITGA2 MDM2 DST GOLGA3 ATPAF1 ABCC1 RAP1GDS1 CDC37 MTIF2 PEAK1 PLCH1 PARD3 ATP2B1 | 2.06e-07 | 262 | 220 | 15 | int:DIRAS3 |
| Interaction | MOB3C interactions | EPPK1 PSMA7 CKAP5 PSMC1 PSMC3 NASP PSMC6 SRPRA MDN1 KIF5B NELFB POR CCT4 CDC37 PDCD5 CTNNA1 | 2.70e-06 | 364 | 220 | 16 | int:MOB3C |
| Interaction | KCNA3 interactions | CTNNAL1 EPPK1 ERC1 CKAP5 PSMC1 SRPRA IQGAP1 DST KIF5B IQGAP3 PLS3 KIF11 RANGAP1 HDAC6 IFT20 LZTFL1 NUMA1 FARSB CCT4 PDIA4 CSK CTNNA1 PEAK1 PLCH1 PARD3 ATP2B1 | 3.40e-06 | 871 | 220 | 26 | int:KCNA3 |
| Interaction | YWHAZ interactions | MYH11 ERC1 CKAP5 PARD6G PFAS SRPRA MDM2 DST PARD6A KIF5B NOS1 GOLGA3 KIF11 BNIP5 KRT78 HDAC6 NELFA SAMD4B BAG5 BAG3 NELFB OBSL1 SIL1 CDC37 CSK GCC2 H2AX GSDMA PEAK1 PLCH1 PARD3 CDC25A ATP2B1 | 6.86e-06 | 1319 | 220 | 33 | int:YWHAZ |
| Interaction | CAPZB interactions | BRPF3 MYH11 MYO5B ERC1 PSMA7 PSMC1 RNF40 SOWAHC CNOT8 IQGAP1 CNOT7 KIF5B PLS3 HDAC6 NELFA MTHFD1L BAG5 BAG3 NUMA1 OBSL1 CCT4 LCP1 CDC37 LUC7L2 NINL GSDMA DDX53 PEAK1 | 1.15e-05 | 1049 | 220 | 28 | int:CAPZB |
| Interaction | NME8 interactions | 1.27e-05 | 14 | 220 | 4 | int:NME8 | |
| Interaction | BRCA1 interactions | ERC1 PSMA7 CKAP5 PSMC1 PSMC3 PSMC6 ACTN3 IQGAP1 CDCA2 RMI1 DST MDN1 MLH1 DCLRE1A GCC1 KIF5B TSGA10IP KIF11 ABCC1 RANGAP1 HUS1 NUMA1 NELFB FARSB CCT4 MSH3 PDIA4 CDC37 NINL H2AX CTNNA1 | 1.58e-05 | 1249 | 220 | 31 | int:BRCA1 |
| Interaction | BAP1 interactions | EPPK1 ERC1 ESD PSMA7 CKAP5 PSMC1 PSMC3 NASP PSMC6 PFAS IQGAP1 EIF3CL DST MDN1 UGP2 KIF5B IQGAP3 PLS3 KIF11 FKBP10 RANGAP1 BAG5 LZTFL1 BAG3 FARSB CCT4 LCP1 PDIA4 CDC37 LUC7L2 PDCD5 NEMF | 1.65e-05 | 1314 | 220 | 32 | int:BAP1 |
| Interaction | CBY2 interactions | 1.78e-05 | 135 | 220 | 9 | int:CBY2 | |
| Interaction | KCTD13 interactions | MYH11 MYO5B ERC1 PSMA7 FKBP9 CKAP5 PSMC1 PSMC3 ITGA2 ACTN3 IQGAP1 DST SACS UGP2 KIF5B NOS1 PLS3 GOLGA3 RAP1GDS1 SYNE1 PCLO POR FARSB CCT4 SHROOM2 CDC37 ARHGAP5 GUCY1A2 SUGP2 CTNNA1 PEAK1 PLCH1 ATP2B1 | 2.13e-05 | 1394 | 220 | 33 | int:KCTD13 |
| Interaction | HMGA2 interactions | 2.38e-05 | 140 | 220 | 9 | int:HMGA2 | |
| Interaction | TRIM51 interactions | 2.51e-05 | 6 | 220 | 3 | int:TRIM51 | |
| Interaction | PMS2 interactions | 2.71e-05 | 80 | 220 | 7 | int:PMS2 | |
| Interaction | CCDC74B interactions | 2.74e-05 | 33 | 220 | 5 | int:CCDC74B | |
| Interaction | FHL2 interactions | ZNF143 MYT1 SREBF2 MDM2 CNOT8 IQGAP1 BBX CNOT7 KIF5B BAG5 E4F1 CARD8 CSK CCAR1 ZNF76 | 3.21e-05 | 396 | 220 | 15 | int:FHL2 |
| Interaction | MFN2 interactions | 3.69e-05 | 148 | 220 | 9 | int:MFN2 | |
| Interaction | CDC42 interactions | A2M ABCA1 CTNNAL1 FKBP9 NASP PARD6G PSMC6 SRPRA SOWAHC IQGAP1 EIF3CL ARHGAP22 BBX MDN1 PARD6A DIAPH2 IQGAP3 FKBP10 ABCC1 RAP1GDS1 HDAC6 SYNE1 POR MSH3 FMNL3 ARHGAP5 PDCD5 CTNNA1 PEAK1 PARD3 ATP2B1 | 4.73e-05 | 1323 | 220 | 31 | int:CDC42 |
| Interaction | BIRC3 interactions | MAGEA11 PSMA7 CKAP5 PSMC1 PSMC3 NASP PSMC6 PFAS IQGAP1 EIF3CL CDCA2 MDN1 SUPV3L1 KIF5B PLS3 KIF11 RANGAP1 RIPK3 MTHFD1L SYNE1 NUMA1 POR FARSB H2AC21 CCT4 PDIA4 CDC37 CCAR1 PEAK1 GFM1 ATP2B1 | 5.52e-05 | 1334 | 220 | 31 | int:BIRC3 |
| Interaction | MYLK4 interactions | 5.82e-05 | 90 | 220 | 7 | int:MYLK4 | |
| Interaction | PINK1 interactions | A2M KLK7 EPPK1 PSMA7 PSMC6 PFAS IQGAP1 DST PLS3 KIF11 BAG5 BAG3 NUMA1 POR FARSB CCT4 PDIA4 CDC37 SUGP2 GSDMA | 5.87e-05 | 679 | 220 | 20 | int:PINK1 |
| Interaction | DDI2 interactions | 6.60e-05 | 124 | 220 | 8 | int:DDI2 | |
| Interaction | YWHAH interactions | MYH11 EPPK1 ERC1 CKAP5 PSMC3 PARD6G IQGAP1 CDCA2 FAM117A DST PARD6A DCLRE1A KIF5B KIF11 KRT78 SAMD4B BAG3 NELFB PDIA4 CDC37 CSK NINL NCOA7 PEAK1 PLCH1 PARD3 CDC25A | 7.28e-05 | 1102 | 220 | 27 | int:YWHAH |
| Interaction | MSN interactions | CKAP5 PSMC3 PSMC6 PFAS PLS3 RAP1GDS1 HDAC6 LCP1 SHROOM2 PDIA4 CDC37 H2AX CTNNA1 | 7.32e-05 | 330 | 220 | 13 | int:MSN |
| Interaction | H2BC5 interactions | A2M CKAP5 IQGAP1 DST HDAC6 PCLO NUMA1 H2AC21 PDIA4 H2AC1 NEMF NINL H2AX | 7.54e-05 | 331 | 220 | 13 | int:H2BC5 |
| Interaction | MRE11 interactions | BRPF3 MDM2 TRIM66 MLH1 KIF5B HDAC6 POLA1 NUMA1 NELFB OBSL1 GCC2 H2AX | 7.90e-05 | 287 | 220 | 12 | int:MRE11 |
| Interaction | TSC22D2 interactions | 8.32e-05 | 66 | 220 | 6 | int:TSC22D2 | |
| Interaction | ZNF598 interactions | EPPK1 CKAP5 PSMC1 PSMC3 PSMC6 SRPRA RNF40 KIF5B KIF11 POR CCT4 NINL CCAR1 GSDMA ATP2B1 | 9.26e-05 | 435 | 220 | 15 | int:ZNF598 |
| Interaction | UBE2M interactions | PSMA7 CKAP5 PSMC1 PSMC3 NASP PSMC6 SRPRA MDM2 IQGAP1 EIF3CL RHOBTB1 PLS3 KIF11 RANGAP1 HDAC6 BAG3 CCT4 PDIA4 CDC37 | 1.02e-04 | 651 | 220 | 19 | int:UBE2M |
| Interaction | CIT interactions | MYH11 EPPK1 ERC1 CKAP5 PSMC3 PSMC6 PFAS SRPRA RNF40 CTIF ACTN3 IQGAP1 EIF3CL PLS3 KIF11 RANGAP1 SYNE1 PCLO NUMA1 OBSL1 POR H2AC21 CCT4 POLR3C LUC7L SUGP2 H2AC1 H2AX CTNNA1 PARD3 CDC25A CCDC180 | 1.09e-04 | 1450 | 220 | 32 | int:CIT |
| Interaction | GBF1 interactions | ERC1 ECHDC1 PSMA7 CKAP5 ITGAD KIF5B PLS3 GOLGA3 KIF11 RANGAP1 HDAC6 BAG3 CSK PDCD5 ATP2B1 | 1.10e-04 | 442 | 220 | 15 | int:GBF1 |
| Interaction | ISG15 interactions | EPPK1 PSMA7 PSMC1 PSMC3 PSMC6 IQGAP1 UGP2 PLS3 HDAC6 BAG5 BAG3 POR CCT4 IFIT1 TKFC ATP2B1 | 1.12e-04 | 494 | 220 | 16 | int:ISG15 |
| Interaction | FLCN interactions | 1.14e-04 | 100 | 220 | 7 | int:FLCN | |
| Interaction | CRACR2B interactions | 1.24e-04 | 24 | 220 | 4 | int:CRACR2B | |
| Interaction | PSMA2 interactions | 1.27e-04 | 214 | 220 | 10 | int:PSMA2 | |
| Interaction | EZR interactions | CTNNAL1 FKBP9 MDM2 IQGAP1 DST PLS3 GOLGA3 RAP1GDS1 LZTFL1 BAG3 OBSL1 FARSB LCP1 NEMF CTNNA1 PEAK1 ATP2B1 | 1.29e-04 | 553 | 220 | 17 | int:EZR |
| Interaction | TRIM33 interactions | ERC1 CKAP5 NASP PFAS RNF40 IQGAP1 EIF3CL KIF5B PLS3 KIF11 COL6A3 HDAC6 MTHFD1L PDIA4 CTNNA1 | 1.45e-04 | 453 | 220 | 15 | int:TRIM33 |
| Interaction | PSMA8 interactions | 1.46e-04 | 73 | 220 | 6 | int:PSMA8 | |
| Interaction | EPB41L4A interactions | 1.54e-04 | 140 | 220 | 8 | int:EPB41L4A | |
| Interaction | CYP2C9 interactions | 1.55e-04 | 105 | 220 | 7 | int:CYP2C9 | |
| Interaction | IKBKE interactions | 1.64e-04 | 106 | 220 | 7 | int:IKBKE | |
| Interaction | UNK interactions | CKAP5 CNOT8 DST CNOT7 UGP2 MLLT6 PLS3 BAG3 CCT4 TRAPPC8 ARHGAP5 GHITM CTNNA1 ATP2B1 | 1.67e-04 | 408 | 220 | 14 | int:UNK |
| Interaction | CCR1 interactions | A2M KLK7 EPPK1 CKAP5 TUFT1 UGP2 C5 BBOX1 PLS3 POR H2AC21 LCP1 GSDMA | 1.79e-04 | 361 | 220 | 13 | int:CCR1 |
| Interaction | RAD23A interactions | 1.84e-04 | 224 | 220 | 10 | int:RAD23A | |
| Interaction | VCP interactions | EPPK1 PSMA7 PSMC1 PSMC3 NASP PSMC6 PFAS MDM2 CNOT8 IQGAP1 EIF3CL MDN1 RHOBTB1 UGP2 IQGAP3 PLS3 GOLGA3 ABCC1 HDAC6 BAG5 NUMA1 OBSL1 POR FARSB CCT4 POLR3C CDC37 CSK H2AX CTNNA1 CDC25A | 2.07e-04 | 1435 | 220 | 31 | int:VCP |
| Interaction | FLOT1 interactions | ABCA1 CTNNAL1 IQGAP1 DST ABCC1 HDAC6 PCLO OBSL1 CCT4 MYH15 CTNNA1 PEAK1 PLCH1 PARD3 ATP2B1 | 2.41e-04 | 475 | 220 | 15 | int:FLOT1 |
| Interaction | YWHAE interactions | MYH11 ERC1 PSMA7 CKAP5 PSMC1 PARD6G COL6A5 IQGAP1 DST KIF5B GOLGA3 BNIP5 RAP1GDS1 HDAC6 SAMD4B BAG3 NELFB OBSL1 SHROOM2 PDIA4 CDC37 CSK GCC2 H2AX PEAK1 PLCH1 PARD3 CDC25A | 2.60e-04 | 1256 | 220 | 28 | int:YWHAE |
| Interaction | ANAPC2 interactions | 2.62e-04 | 234 | 220 | 10 | int:ANAPC2 | |
| GeneFamily | PDZ domain containing | 1.75e-04 | 152 | 139 | 7 | 1220 | |
| GeneFamily | EF-hand domain containing | 2.95e-04 | 219 | 139 | 8 | 863 | |
| GeneFamily | Proteasome | 3.27e-04 | 43 | 139 | 4 | 690 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 3.33e-04 | 18 | 139 | 3 | 1160 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinase kinases | 5.78e-04 | 5 | 139 | 2 | 655 | |
| GeneFamily | AAA ATPases | 7.32e-04 | 53 | 139 | 4 | 413 | |
| GeneFamily | BCL2 associated athanogene family | 8.63e-04 | 6 | 139 | 2 | 1139 | |
| GeneFamily | Clustered protocadherins | 1.49e-03 | 64 | 139 | 4 | 20 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.59e-03 | 8 | 139 | 2 | 939 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 2.04e-03 | 9 | 139 | 2 | 1234 | |
| GeneFamily | CCR4-NOT transcription complex | 3.08e-03 | 11 | 139 | 2 | 1023 | |
| GeneFamily | ATP binding cassette subfamily A | 5.03e-03 | 14 | 139 | 2 | 805 | |
| GeneFamily | Myosin heavy chains | 5.77e-03 | 15 | 139 | 2 | 1098 | |
| GeneFamily | ATPase phospholipid transporting | 5.77e-03 | 15 | 139 | 2 | 1210 | |
| GeneFamily | Potassium voltage-gated channel subfamily J | 6.56e-03 | 16 | 139 | 2 | 276 | |
| Coexpression | GSE21927_GMCSF_IL6_VS_GMCSF_GCSF_TREATED_BONE_MARROW_DN | CTNNAL1 PSMA7 PSMC3 NASP PSMC6 SRPRA BNIP1 MLH1 RANGAP1 PDIA4 | 8.59e-06 | 200 | 222 | 10 | M7609 |
| Coexpression | GSE3982_NKCELL_VS_TH2_DN | 8.59e-06 | 200 | 222 | 10 | M5598 | |
| Coexpression | SENESE_HDAC3_TARGETS_DN | BRPF3 MYO5B FKBP9 PARD6G CTIF TUFT1 BBX GOLGA3 ATPAF1 SYNE1 PCLO OBSL1 TFDP1 H2AX PARD3 CDC25A | 1.96e-05 | 548 | 222 | 16 | M16859 |
| Coexpression | KRAS.DF.V1_DN | 4.21e-05 | 193 | 222 | 9 | M2861 | |
| Coexpression | HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_56D_TOP_100_DEG_AFTER_IN_VITRO_RE_STIMULATION_DN | 4.78e-05 | 47 | 222 | 5 | M40911 | |
| Coexpression | GSE1460_INTRATHYMIC_T_PROGENITOR_VS_CD4_THYMOCYTE_UP | 5.33e-05 | 199 | 222 | 9 | M3439 | |
| Coexpression | GSE22886_UNSTIM_VS_IL2_STIM_NKCELL_DN | 5.54e-05 | 200 | 222 | 9 | M4531 | |
| Coexpression | GSE1448_CTRL_VS_ANTI_VALPHA2_DP_THYMOCYTE_UP | 5.54e-05 | 200 | 222 | 9 | M3425 | |
| Coexpression | GSE21546_WT_VS_SAP1A_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN | 5.54e-05 | 200 | 222 | 9 | M7532 | |
| Coexpression | GSE3982_NKCELL_VS_TH1_DN | 5.54e-05 | 200 | 222 | 9 | M5595 | |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | ZNF143 SRPRA CNOT7 ST13P5 KIF11 RANGAP1 HUS1 POLA1 LCP1 POLR3C ARHGAP5 LPA NEMF CCAR1 ATP2B1 | 6.68e-05 | 543 | 222 | 15 | MM997 |
| ToppCell | MatrixFB-Fibroblast-E_(Early_Fibroblastic_progenitor)|MatrixFB / shred on cell class and cell subclass (v4) | 4.40e-07 | 188 | 221 | 9 | b240ea20750ffb825cb5fe41d06c632233406ab6 | |
| ToppCell | wk_15-18-Endothelial-Lymph_endothelial-Lymphatic_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.73e-07 | 194 | 221 | 9 | bc03d0f8dca9f4ba10db2f2274293f8b119e8951 | |
| ToppCell | wk_15-18-Endothelial-Lymph_endothelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.24e-07 | 196 | 221 | 9 | ff627244d7f5fd6a2ec009dae32d3509f0e2d95e | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | 6.79e-07 | 198 | 221 | 9 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.77e-06 | 165 | 221 | 8 | 347b59aa625a8a960828b8620824d8ac48990e07 | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.77e-06 | 165 | 221 | 8 | 1890f9c33b0c5b381d57f97042da2610a093a6de | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.77e-06 | 165 | 221 | 8 | 507c89ece0a336b8e9c65b79889a714e17ddca27 | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.77e-06 | 165 | 221 | 8 | 39a25be081a5d59c7cf107a997d352793d5025fb | |
| ToppCell | droplet-Heart-HEART-1m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-06 | 173 | 221 | 8 | 9dc7746a84f0e268a7c061e1bbcd5e31903034dc | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.63e-06 | 174 | 221 | 8 | f90ca117b729436cf452e2ddcec26ba525c5c13b | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.24e-06 | 179 | 221 | 8 | 54191c00b29f53b520cd3243b5791daa4a2c72d7 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.38e-06 | 180 | 221 | 8 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-06 | 184 | 221 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-06 | 184 | 221 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-06 | 184 | 221 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | Endothelial-Endothelial-D_(cycle)|Endothelial / shred on cell class and cell subclass (v4) | 5.23e-06 | 191 | 221 | 8 | a3c5a913a99f17633c140ec9ece81b73e59e0715 | |
| ToppCell | wk_20-22-Endothelial-Lymph_endothelial-Lymphatic_endo|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.87e-06 | 194 | 221 | 8 | 640ff8da7084a9486fc2752493b8d8059ecf4ab7 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 6.09e-06 | 195 | 221 | 8 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Fibroblastic-Fibro_immune_recruiting|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.57e-06 | 197 | 221 | 8 | 4edf043e8f586fd375f56485841fe992a18bf853 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.57e-06 | 197 | 221 | 8 | 156155c2f0c1a2461e45803da578af18ee221660 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G-|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.57e-06 | 197 | 221 | 8 | d5d9263451f6c10cb3b9c17740183ca334e24851 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.82e-06 | 198 | 221 | 8 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | Fibroblasts|World / lung cells shred on cell class, cell subclass, sample id | 7.07e-06 | 199 | 221 | 8 | e2b6752fcabd5249a166486ae6796f2c97c1fcaf | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 7.07e-06 | 199 | 221 | 8 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 7.33e-06 | 200 | 221 | 8 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.33e-06 | 200 | 221 | 8 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.33e-06 | 200 | 221 | 8 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 7.33e-06 | 200 | 221 | 8 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 7.33e-06 | 200 | 221 | 8 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.33e-06 | 200 | 221 | 8 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.16e-05 | 153 | 221 | 7 | 991782d111d66e25b40319d4e6dea40f2c2c0805 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.96e-05 | 166 | 221 | 7 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.20e-05 | 169 | 221 | 7 | f077e39e41fffe7672541f5b72b80faaf56c597c | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.20e-05 | 169 | 221 | 7 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | Lymphoid-Lymphoid-B_cells_(cycle)|Lymphoid / shred on cell class and cell subclass (v4) | 2.47e-05 | 172 | 221 | 7 | f39822afcc35f0fbf68b8ffd1894e4b6c8d7a80c | |
| ToppCell | Control-Myeloid-MoAM2,_CCL18|Control / Condition, Lineage and Cell class | 2.66e-05 | 174 | 221 | 7 | 4c64ff5666812fb4efa440ba4faeca51d916d68e | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-05 | 175 | 221 | 7 | f6e1d7297a4dbb38e1ab4f738d91f0e62abaee69 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nptxr-Excitatory_Neuron.Slc17a7.Nptxr-Drd1_(Deep_layer_pyramidal_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.86e-05 | 176 | 221 | 7 | 3c76a5c4ca2b378667cb155fbb9675519572b35d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.96e-05 | 177 | 221 | 7 | f4ddf0ef0eade13b9835a5684a8dbb6f71be4697 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.96e-05 | 177 | 221 | 7 | 67cc3a6461db5e0678f96b18224aeb83ad34b0f4 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-05 | 178 | 221 | 7 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-Alveolar_Epithelial_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-05 | 179 | 221 | 7 | 88dbec952507d84b85b08165eec80df99ed1e736 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-type_I_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-05 | 179 | 221 | 7 | daf8189a22786171e2b629261cf720736aa4ebdb | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.30e-05 | 180 | 221 | 7 | 5e1680088065be14447d5d5465f91f7edd071a1e | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.30e-05 | 180 | 221 | 7 | 92fb01b91261b3103454924cde56add337b41844 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.42e-05 | 181 | 221 | 7 | 92d44892bb15771f0ab5fe61879b204b0acbd9b3 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.42e-05 | 181 | 221 | 7 | b244ecaa442bbef51289d8ec574ef08fa9e96318 | |
| ToppCell | normal_Lung-Fibroblasts-Pericytes|normal_Lung / Location, Cell class and cell subclass | 3.42e-05 | 181 | 221 | 7 | f74941e49950027360d71ea3b205fc20c6929766 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.42e-05 | 181 | 221 | 7 | dd79de8098edb385a0f85d0e9621503cdf76ec43 | |
| ToppCell | NS-critical-d_07-13-Lymphoid-NK|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.54e-05 | 182 | 221 | 7 | dd1c59babf7211362452e3e264009d70004d99f6 | |
| ToppCell | Endothelial-G|World / shred on cell class and cell subclass (v4) | 3.62e-05 | 124 | 221 | 6 | 4b72809463f2986b7d1b7ab9de633ac4d7854a92 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.67e-05 | 183 | 221 | 7 | 764ea07621f77fbd13a877aed5806ae2b3dfb43e | |
| ToppCell | COVID-19_Mild-NK_activated|COVID-19_Mild / Disease condition and Cell class | 3.67e-05 | 183 | 221 | 7 | 22bd05135906d0ecc4ba8c2e0a666093d1bf3b8f | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 3.67e-05 | 183 | 221 | 7 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.80e-05 | 184 | 221 | 7 | 688428103e8b19f45f2f65d70a0f30c904c8411c | |
| ToppCell | droplet-Lung-nan-3m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.93e-05 | 185 | 221 | 7 | 6a85399cfdb9b89683c874e7f046957f9a601dc2 | |
| ToppCell | facs-Large_Intestine-Proximal-24m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.93e-05 | 185 | 221 | 7 | 2a8104f610fa5ce618f8105521616722462a0d42 | |
| ToppCell | droplet-Lung-nan-3m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.93e-05 | 185 | 221 | 7 | 64791056cdbb739136dbef08f4b16e2b5427faad | |
| ToppCell | 368C-Myeloid-Dendritic-cDC_proliferating_1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 4.07e-05 | 186 | 221 | 7 | 5cadab3271fce9ab6da3d7ba9827b8a221cac166 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-proliferating_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.07e-05 | 186 | 221 | 7 | a844d4f79e0ad5d6c60a4488ffd8f4f21b7eed04 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 4.21e-05 | 187 | 221 | 7 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 4.35e-05 | 188 | 221 | 7 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | Fibroblast-E_(Early_Fibroblastic_progenitor)|World / shred on cell class and cell subclass (v4) | 4.35e-05 | 188 | 221 | 7 | be3db9768364568f44e32ae6b3bf99e49b0978bb | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.50e-05 | 189 | 221 | 7 | 6dd4ec5ce4beb856f0d2d1654e3c4676d1d63736 | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.50e-05 | 189 | 221 | 7 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.50e-05 | 189 | 221 | 7 | 875df61ee48baa5142ba4d2427bdec1c53e5a828 | |
| ToppCell | COVID_vent-Myeloid-Monocytic-SC_&_Eosinophil|COVID_vent / Disease condition, Lineage, Cell class and subclass | 4.50e-05 | 189 | 221 | 7 | 2157a2d40613f7d5ce2e7dbd266df441e449cdaf | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.50e-05 | 189 | 221 | 7 | 3ae479ec7e00c57127cbe51a398329b10ca9848c | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.50e-05 | 189 | 221 | 7 | 97ef5215d841ff366a3e3682cd9bd04100cbfde0 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 4.65e-05 | 190 | 221 | 7 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.65e-05 | 190 | 221 | 7 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-matrix_-_immature_4|E18.5-samps / Age Group, Lineage, Cell class and subclass | 4.71e-05 | 130 | 221 | 6 | 169d88bffd7cd813a484d809defa638ceaca4bcb | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.81e-05 | 191 | 221 | 7 | 48823a97c38263f2c6e58348214f5b62773a6368 | |
| ToppCell | wk_20-22-Endothelial-Lymph_endothelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.81e-05 | 191 | 221 | 7 | 631f95fd80dd3678b5b2ef201abf7fe646049af6 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.81e-05 | 191 | 221 | 7 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.81e-05 | 191 | 221 | 7 | 0eedc66e967b1837ce2c14f8c14b3c1eba868c76 | |
| ToppCell | Endothelial-D_(cycle)|World / shred on cell class and cell subclass (v4) | 4.81e-05 | 191 | 221 | 7 | 49a4d8f181558e3be9527a8ff9a178f3bb01323c | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.81e-05 | 191 | 221 | 7 | f932980baa032748857cb367a55c37dd975c693e | |
| ToppCell | 368C-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.97e-05 | 192 | 221 | 7 | b016e229300c183e14c0e2bba494bf49c7899112 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.97e-05 | 192 | 221 | 7 | ac96831492c62ad9e1f7d0b764fbdf7d8a189ad9 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.97e-05 | 192 | 221 | 7 | 5388f3115ab285f3f3001af1d71543ed64b9e044 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.97e-05 | 192 | 221 | 7 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.97e-05 | 192 | 221 | 7 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 5.14e-05 | 193 | 221 | 7 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 5.14e-05 | 193 | 221 | 7 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.14e-05 | 193 | 221 | 7 | 9ab47b360bee1d4f1092c2269e58acebe9584021 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.14e-05 | 193 | 221 | 7 | ef007b736da56529ec628fc3df86a335e7ec3f18 | |
| ToppCell | CTRL-Epithelial|CTRL / Disease state, Lineage and Cell class | 5.31e-05 | 194 | 221 | 7 | 49dcb31427f370692308f939e23992925708abb7 | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 5.31e-05 | 194 | 221 | 7 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | CTRL-Epithelial-Epithelial_cell|CTRL / Disease state, Lineage and Cell class | 5.31e-05 | 194 | 221 | 7 | 2bc4deaf2a01a39809fc323962fce4286835209c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.48e-05 | 195 | 221 | 7 | ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 5.48e-05 | 195 | 221 | 7 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.48e-05 | 195 | 221 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.48e-05 | 195 | 221 | 7 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.48e-05 | 195 | 221 | 7 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.48e-05 | 195 | 221 | 7 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.48e-05 | 195 | 221 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.66e-05 | 196 | 221 | 7 | e7bfd4fb400ae0c473131d0fa306c26be08a6d03 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.66e-05 | 196 | 221 | 7 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.66e-05 | 196 | 221 | 7 | 85e5046f774537684e1443c0fc147d562b7068d0 | |
| Drug | 2,3-bis(3'-hydroxybenzyl)butyrolactone | CTNNAL1 MYO5B CKAP5 PSMC3 NASP ITGA2 TUFT1 CDCA2 RMI1 MLH1 KDR DCLRE1A C5 IQGAP3 KIF11 ENOSF1 RANGAP1 IFT20 POLA1 BAG3 TFDP1 TKFC NINL H2AX NCOA7 CDC25A ATP2B1 | 6.29e-07 | 961 | 219 | 27 | ctd:C029497 |
| Drug | magnesium | CNNM2 MYH11 ZNF143 MYO5B CTRC ITGA2 ITGAD ITGAM CNOT8 KCNJ12 UGP2 MLH1 GTPBP3 NOS1 PLS3 PKN3 KIF11 ABCC1 RANGAP1 MTHFD1L POLA1 FARSB CCT4 NLRP14 TKFC GUCY1A2 CSK GUCY2C GCC2 ATP6V0A4 GFM1 ATP2B1 | 1.47e-06 | 1325 | 219 | 32 | CID000000888 |
| Drug | hydroxylamine | A2M HECW1 ERC1 CTRC ITGA2 MLH1 NOS1 POR TKFC GUCY2C MTIF2 CDC25A | 4.64e-06 | 244 | 219 | 12 | CID000000787 |
| Disease | xylonate measurement, arabonate measurement | 4.99e-05 | 2 | 209 | 2 | EFO_0800147, EFO_0801066 | |
| Disease | transient cerebral ischemia (implicated_via_orthology) | 9.23e-05 | 64 | 209 | 5 | DOID:224 (implicated_via_orthology) | |
| Disease | Beta blocking agent use measurement | 1.66e-04 | 114 | 209 | 6 | EFO_0009929 | |
| Disease | esterified cholesterol measurement, high density lipoprotein cholesterol measurement | 3.12e-04 | 19 | 209 | 3 | EFO_0004612, EFO_0008589 | |
| Disease | cerebral infarction (is_marker_for) | 3.12e-04 | 19 | 209 | 3 | DOID:3526 (is_marker_for) | |
| Disease | Hereditary Non-Polyposis Colon Cancer Type 2 | 3.12e-04 | 19 | 209 | 3 | C1333991 | |
| Disease | hypertension | 3.65e-04 | 307 | 209 | 9 | EFO_0000537 | |
| Disease | hereditary sensory neuropathy (implicated_via_orthology) | 4.92e-04 | 5 | 209 | 2 | DOID:0050548 (implicated_via_orthology) | |
| Disease | Aneuploidy | 4.92e-04 | 5 | 209 | 2 | C0002938 | |
| Disease | Cis-4-decenoyl carnitine measurement | 4.92e-04 | 5 | 209 | 2 | EFO_0022091 | |
| Disease | Colorectal Carcinoma | ABCA1 CLSTN2 JAKMIP2 ABCA9 SACS SCNN1B MLH1 KDR ABCC1 MTHFD1L SYNE1 GUCY1A2 GUCY2C CCAR1 | 5.18e-04 | 702 | 209 | 14 | C0009402 |
| Disease | Abnormality of vision | 7.35e-04 | 6 | 209 | 2 | C4025846 | |
| Disease | systemic lupus erythematosus, COVID-19 | 7.69e-04 | 58 | 209 | 4 | MONDO_0007915, MONDO_0100096 | |
| Disease | Hereditary Nonpolyposis Colorectal Neoplasms | 8.08e-04 | 26 | 209 | 3 | C0009405 | |
| Disease | Colorectal Neoplasms | 8.49e-04 | 277 | 209 | 8 | C0009404 | |
| Disease | migraine disorder, type 2 diabetes mellitus | 8.74e-04 | 60 | 209 | 4 | MONDO_0005148, MONDO_0005277 | |
| Disease | Hereditary non-polyposis colorectal cancer syndrome | 9.04e-04 | 27 | 209 | 3 | C1112155 | |
| Disease | neutropenia (implicated_via_orthology) | 1.02e-03 | 7 | 209 | 2 | DOID:1227 (implicated_via_orthology) | |
| Disease | Hereditary Nonpolyposis Colorectal Cancer | 1.12e-03 | 29 | 209 | 3 | C1333990 | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 1.19e-03 | 111 | 209 | 5 | EFO_0004530, EFO_0008595 | |
| Disease | right ventricular ejection fraction measurement | 1.24e-03 | 30 | 209 | 3 | EFO_0021816 | |
| Disease | vital capacity | ERC1 MYT1 CTIF ACTN3 TRIM66 RMI1 DST CROCC2 SYCP1 KDR TSGA10IP COL6A3 SYNE1 PCLO C16orf96 PCDHA4 MTTP PARD3 TNXB | 1.33e-03 | 1236 | 209 | 19 | EFO_0004312 |
| Disease | non-alcoholic pancreatitis | 1.36e-03 | 8 | 209 | 2 | EFO_0021524 | |
| Disease | Chromosomal Instability | 1.36e-03 | 8 | 209 | 2 | C1257806 | |
| Disease | sarcoma (is_implicated_in) | 1.36e-03 | 8 | 209 | 2 | DOID:1115 (is_implicated_in) | |
| Disease | cholesteryl esters to total lipids in large LDL percentage | 1.36e-03 | 31 | 209 | 3 | EFO_0022249 | |
| Disease | Abnormality of the face | 1.74e-03 | 9 | 209 | 2 | C4025871 | |
| Disease | octanoylcarnitine measurement | 1.74e-03 | 9 | 209 | 2 | EFO_0021042 | |
| Disease | Vasodilators used in cardiac diseases use measurement | 1.78e-03 | 34 | 209 | 3 | EFO_0009926 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 1.80e-03 | 243 | 209 | 7 | EFO_0004612, EFO_0020944 | |
| Disease | cholesteryl esters to total lipids in very large HDL percentage | 2.11e-03 | 36 | 209 | 3 | EFO_0022257 | |
| Disease | abdominal aortic aneurysm (is_marker_for) | 2.16e-03 | 10 | 209 | 2 | DOID:7693 (is_marker_for) | |
| Disease | pulse pressure measurement | BRPF3 CNNM2 MYH11 MYT1 CKAP5 FCSK TRIM66 BNIP1 DCLRE1A KIF5B MAP4K2 COL6A3 MXRA5 CRTAC1 PCDHA4 LCP1 FMNL3 CDC25A TRIM49B ATP2B1 | 2.21e-03 | 1392 | 209 | 20 | EFO_0005763 |
| Disease | Diarrhea | 2.63e-03 | 11 | 209 | 2 | C0011991 | |
| Disease | Hypercholesterolemia | 2.65e-03 | 39 | 209 | 3 | C0020443 | |
| Disease | otosclerosis | 2.66e-03 | 81 | 209 | 4 | EFO_0004213 | |
| Disease | Agents acting on the renin-angiotensin system use measurement | 2.80e-03 | 335 | 209 | 8 | EFO_0009931 | |
| Disease | ciliopathy (implicated_via_orthology) | 2.85e-03 | 40 | 209 | 3 | DOID:0060340 (implicated_via_orthology) | |
| Disease | Inherited neuropathies | 2.85e-03 | 40 | 209 | 3 | C0598589 | |
| Disease | retinopathy of prematurity (biomarker_via_orthology) | 3.14e-03 | 12 | 209 | 2 | DOID:13025 (biomarker_via_orthology) | |
| Disease | mismatch repair cancer syndrome (is_implicated_in) | 3.14e-03 | 12 | 209 | 2 | DOID:0112182 (is_implicated_in) | |
| Disease | response to anticonvulsant | 3.17e-03 | 85 | 209 | 4 | GO_0036277 | |
| Disease | cervix uteri carcinoma in situ (is_marker_for) | 3.28e-03 | 42 | 209 | 3 | DOID:8991 (is_marker_for) | |
| Disease | triglyceride measurement, high density lipoprotein cholesterol measurement | 3.52e-03 | 274 | 209 | 7 | EFO_0004530, EFO_0004612 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 3.66e-03 | 276 | 209 | 7 | EFO_0004612, EFO_0020943 | |
| Disease | saturated fatty acids measurement | 3.99e-03 | 45 | 209 | 3 | EFO_0022304 | |
| Disease | fatty acid measurement | 4.09e-03 | 436 | 209 | 9 | EFO_0005110 | |
| Disease | membranous glomerulonephritis (biomarker_via_orthology) | 4.30e-03 | 14 | 209 | 2 | DOID:10976 (biomarker_via_orthology) | |
| Disease | Gastrointestinal Stromal Sarcoma | 4.52e-03 | 47 | 209 | 3 | C3179349 | |
| Disease | urate measurement, bone density | ERC1 COL6A5 ARHGAP22 RHOBTB1 MTHFD1L SYNE1 LCP1 USP40 CTNNA1 PEAK1 TNXB | 4.86e-03 | 619 | 209 | 11 | EFO_0003923, EFO_0004531 |
| Disease | chronic obstructive pulmonary disease (is_marker_for) | 5.07e-03 | 97 | 209 | 4 | DOID:3083 (is_marker_for) | |
| Disease | unipolar depression, bipolar disorder | 5.17e-03 | 156 | 209 | 5 | EFO_0003761, MONDO_0004985 | |
| Disease | Gastrointestinal Stromal Tumors | 5.37e-03 | 50 | 209 | 3 | C0238198 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 5.39e-03 | 224 | 209 | 6 | EFO_0004530, EFO_0008317 | |
| Disease | Schizoaffective disorder-bipolar type | 5.61e-03 | 16 | 209 | 2 | EFO_0009965 | |
| Disease | cholesterol to total lipids in small HDL percentage | 5.68e-03 | 51 | 209 | 3 | EFO_0022240 | |
| Disease | attention deficit hyperactivity disorder, bipolar disorder, autism spectrum disorder, schizophrenia, major depressive disorder | 5.68e-03 | 51 | 209 | 3 | EFO_0003756, EFO_0003888, MONDO_0002009, MONDO_0004985, MONDO_0005090 | |
| Disease | neurotic disorder | 5.85e-03 | 101 | 209 | 4 | EFO_0004257 | |
| Disease | triglycerides in HDL measurement | 6.33e-03 | 53 | 209 | 3 | EFO_0022317 | |
| Disease | muscular dystrophy (is_implicated_in) | 6.33e-03 | 17 | 209 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | glutarylcarnitine (C5-DC) measurement | 6.33e-03 | 17 | 209 | 2 | EFO_0800030 | |
| Disease | left ventricular diastolic function measurement | 6.66e-03 | 54 | 209 | 3 | EFO_0008204 | |
| Disease | Metastatic melanoma | 6.66e-03 | 54 | 209 | 3 | C0278883 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 6.70e-03 | 166 | 209 | 5 | EFO_0004530, EFO_0004611 | |
| Disease | behavior | 7.01e-03 | 55 | 209 | 3 | GO_0007610 | |
| Disease | triglycerides in very large HDL measurement | 7.01e-03 | 55 | 209 | 3 | EFO_0022324 | |
| Disease | HOMA-B | 7.01e-03 | 55 | 209 | 3 | EFO_0004469 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NDAGRGEINELKQVE | 51 | Q719I0 | |
| DQGKDDQFLLDGQLL | 221 | P10768 | |
| LLEKQGDGEAGVNIV | 706 | P55198 | |
| EKDELGEQVLGLKSQ | 806 | O75150 | |
| SKTELQGLIGQLDEV | 306 | Q9UL15 | |
| QGLIGQLDEVSLEKN | 311 | Q9UL15 | |
| DIDKVQLLGADGLEQ | 51 | Q8WY36 | |
| LAKLGLVLDQAEAEG | 136 | Q13938 | |
| EDGDGINLNDIEKVL | 151 | O43310 | |
| AKEEVNGQVLLESGE | 221 | P30939 | |
| EGNLNLGSLEEKEII | 66 | Q5JQC9 | |
| QLVEKLQGERKEADG | 596 | Q8IX12 | |
| DGAKDIGSLVELEQV | 811 | Q8IUA7 | |
| GLNQELEEVFVKEQG | 216 | Q9C073 | |
| QIQNGEELLSAGKEA | 506 | Q7Z2Y8 | |
| LAVRNDEELNKLLGG | 86 | Q8IUE6 | |
| DEELNKLLGGVTIAQ | 91 | Q8IUE6 | |
| LQDLELALEGALDKG | 296 | Q96QA5 | |
| GKLNLTEVEGLADLI | 151 | Q969Y2 | |
| RILDGGGQNDILEIK | 1901 | O95477 | |
| LDVLKLGEQKQAEAG | 1116 | Q9ULD4 | |
| SNLVQLLGVIVEEKG | 246 | P41240 | |
| VGALQGKVEEDLELL | 486 | Q9P1Z9 | |
| GEENILDKLLGAITT | 286 | O60879 | |
| EGDDIGNINRALQKV | 571 | Q9H4D0 | |
| AVIELLEKSGVNLDG | 206 | Q6UB35 | |
| ADGILIQGNDLKIDE | 226 | P20020 | |
| GNLLGKENDVALIID | 751 | Q9NTI2 | |
| LLNNAIKGGVEDEVT | 1086 | P01023 | |
| LLGATAIEDKLQQGV | 661 | P98198 | |
| AIEVLNDGELQKAID | 121 | Q8NFI4 | |
| KIGGILANELSVDEA | 201 | P46940 | |
| AELEKLDLNGNTLGE | 321 | P46060 | |
| AAGLQAEIGQVKQEL | 461 | Q8IUD2 | |
| LKNLEDAVNEGLEIV | 51 | P25092 | |
| FVANLLKDLGLEIGE | 46 | Q9Y5E7 | |
| DLAEIGIAVGNNDVK | 561 | P33176 | |
| DIKGANLLLTLQGDV | 136 | Q12851 | |
| KDGLEVEASDALQLG | 1116 | O75147 | |
| DGNLVSLEEDLKEGA | 46 | Q8WYQ4 | |
| GEDVNPLIKLDDAVN | 341 | P20585 | |
| DLLGKDNLQATEGLV | 266 | Q8NGS5 | |
| DLIKQLDILGDNGNL | 631 | Q96AA8 | |
| DLLERNAEAIKAGGQ | 71 | Q9NU22 | |
| LNEGGTAELLNKEIL | 141 | Q9NQ48 | |
| KPEEGLQAQEEDLGL | 121 | P43364 | |
| LLAKAEQLGAEGNVD | 136 | Q9NQ29 | |
| LDQIDIDVGFDKGLD | 246 | Q14500 | |
| VNQLGKILGADLDVV | 331 | P16435 | |
| NVQDILGELREKVGE | 116 | Q9H3P2 | |
| TEIGLIVKEAQAQGD | 376 | O60524 | |
| KGDVDGSVEAILNII | 521 | P46199 | |
| LEQKELDQEPGAGLD | 126 | Q9UKP3 | |
| LGLSNEIGAIEKAVI | 101 | Q9H3K2 | |
| DLQKEDNGIGILTLN | 56 | Q9NTX5 | |
| QELGLLIKEVADALG | 56 | Q9NYG8 | |
| QVIGLDAAKQLGIID | 1906 | Q03001 | |
| EGAGELLAQVQKDIQ | 436 | Q76N89 | |
| GNLQIEKVDLRDEGI | 1856 | Q8NDA2 | |
| DGEELVKIGKLNLVD | 251 | P52732 | |
| KQLVAGDIVLDKLGE | 76 | Q9NX04 | |
| EEDALEILQKGQIGK | 161 | Q7L5Y1 | |
| LAIRNDEELNKLLGG | 86 | P16104 | |
| DEELNKLLGGVTIAQ | 91 | P16104 | |
| KEDGKLQLVGDVIDL | 2716 | Q9Y6V0 | |
| GQLSEKVSEQGLIEI | 81 | O14737 | |
| ILEEIGGGQKVNDDI | 506 | P13796 | |
| TLNVLEDLGDGQKAN | 506 | P13797 | |
| EDLGDGQKANDDIIV | 511 | P13797 | |
| GLKANIEVQGGLAID | 746 | P55157 | |
| IAVQELEKLGLGDSV | 26 | Q9NXJ5 | |
| LAEENGIKVGDQVLA | 246 | Q9H5P4 | |
| NNGLTEVLKEIAGLD | 146 | Q9H792 | |
| KDLQQDIADGVLLAE | 101 | Q8IVL0 | |
| LAFQGEKGVQDVLEI | 321 | Q9UJM8 | |
| QDLGVANGEDLKETL | 6 | Q8WX92 | |
| LALETAGEEAQGDKI | 16 | P49862 | |
| KQLEQLQGERGALDA | 171 | Q8N1N4 | |
| QAQLEKELEGGTLFE | 261 | P16050 | |
| LGKEQQEGLAEAVLE | 636 | A0A1B0GTW7 | |
| DNKIQGDLAGRAEIL | 81 | Q9BX67 | |
| VNLAKDLGLAEGELA | 46 | Q9UN67 | |
| QLDLTEQQGRKELEG | 1306 | Q08378 | |
| DEAALLEKAGTLGEQ | 346 | P17301 | |
| VDLSKDGLLGDILQD | 151 | P09884 | |
| KIGGILANELSVDEA | 191 | Q86VI3 | |
| SENEAGKAVLEQLVG | 321 | P49321 | |
| VLEVNGIEVAGKTLD | 216 | Q9BYG4 | |
| LQGRGENNELLKEIE | 196 | P29475 | |
| GAALTVLGDVNEDKL | 521 | Q13349 | |
| LEVNGIEVAGKTLDQ | 216 | Q9NPB6 | |
| VIKLNASDLDEGLNG | 261 | Q9UN74 | |
| LFEEIDKDGNGEVLL | 496 | O95302 | |
| LIQEDILDTGNDKNG | 121 | P30990 | |
| EALEAVLAKTEGLGN | 1041 | Q8N0W3 | |
| IAAENNLGEGVIVKI | 361 | B5ME19 | |
| KGGLQEVAEQLELER | 206 | Q9UIV1 | |
| KGEAVQEELLKGLDN | 121 | Q14008 | |
| QEATLGANKVIEGLD | 426 | Q96AY3 | |
| LEGELKGLQEQIAET | 211 | Q96CN9 | |
| GNLGKELEAAQEQLA | 511 | Q96CN9 | |
| LKAVGLEDQIVSQGI | 66 | O15229 | |
| KLVALLQEVDGQLGQ | 541 | P0C671 | |
| VGKNNLEVEDEEGSL | 86 | Q99895 | |
| LKELEQAEQGQGLLE | 236 | Q14183 | |
| VVEDGILKLRNAGNE | 156 | P35221 | |
| LKLTGVEGNLEALAE | 421 | Q9UBT7 | |
| GEALQLAAVQVKGEE | 446 | A6NNT2 | |
| AEQLVEILEAKADGQ | 161 | Q9Y6A2 | |
| GGKAELERLQAEAQQ | 76 | Q16543 | |
| EQLEGQAALLGREKA | 701 | H7BZ55 | |
| GQLQKALAEAEEGQR | 1411 | H7BZ55 | |
| EVLLENGDINRKVLG | 56 | Q8WVC6 | |
| VIAELEQSGLGAELK | 306 | Q5TC12 | |
| VKELGVVLGIESNDL | 1081 | Q9P278 | |
| VGGLLEDAETKNVAL | 381 | Q8IVF7 | |
| ILELAAQVLEDKGVG | 91 | P31415 | |
| VGIGAANKIELQEIA | 576 | A8TX70 | |
| GISANEEDLKALVEG | 1431 | P01031 | |
| AIGNKGADQAELEEI | 581 | P12111 | |
| VLLALKLQDEGQEAE | 221 | Q5T764 | |
| LEQKVNELTGGLEET | 641 | Q8IWJ2 | |
| LAENDAIKLQLVEAG | 251 | P52306 | |
| EALDVNIGIKGLIFD | 56 | O75936 | |
| GDLKGVLDDLQDNEV | 466 | Q9Y2G2 | |
| GNELVVKELLTQGAD | 706 | Q9P2S6 | |
| GTGLLKEAQLLVIEN | 1951 | P08519 | |
| VLLALKLQDEGQEAE | 221 | P09914 | |
| DENLTDAEGKVIGLQ | 211 | Q69YH5 | |
| NGQIEDISKGVDIII | 336 | Q86TM3 | |
| KGGLQEVADQLDLQR | 206 | Q9UFF9 | |
| VLVDGDLNLGSVVKE | 641 | Q9NQ79 | |
| VGGLIELVDQLAKEA | 51 | Q8IY31 | |
| EEKLLGESALEGINL | 571 | Q6PJP8 | |
| LGLAGEGEQAQVKLL | 171 | Q66K89 | |
| EALAGTGLVLDEQLN | 81 | Q9UBN7 | |
| KDVVENGLIAGAVDL | 511 | Q5W0V3 | |
| LAIRNDEELNKLLGG | 86 | Q96QV6 | |
| DEELNKLLGGVTIAQ | 91 | Q96QV6 | |
| EAILEKVQGLEQAVD | 426 | O95817 | |
| VNLILTVADGDKDGQ | 171 | Q5T7M9 | |
| GLEGNFKGIVDLIEE | 206 | Q96RP9 | |
| TEFGLKLILDIGQED | 291 | P51168 | |
| GQILKELIQNAEDAG | 111 | Q9NZJ4 | |
| AVGEALKANNVLEEL | 266 | Q6ZQY2 | |
| DGFVDLLDGENLKNE | 216 | P30304 | |
| GEVLGDVLQLETLKQ | 406 | Q14980 | |
| QLLGEISKDGEVLLQ | 231 | A6NGG8 | |
| LIEVNGVDLVGKSQE | 511 | Q8TEW0 | |
| RLGAGEQDAEEIKVQ | 801 | Q6P5Z2 | |
| EEIGKLLAKVEQLGA | 131 | Q9Y383 | |
| LLAKVEQLGAEGNVE | 136 | Q9Y383 | |
| VNLAKDLGLAEGELA | 46 | Q9Y5E1 | |
| SAEGEIIIDGINIAK | 1346 | P33527 | |
| DVILVGEQAKAQDGL | 451 | P33402 | |
| RDIKGANILINDAGE | 136 | Q92918 | |
| VAEEILIKGINAGQL | 186 | A6NKG5 | |
| ALGLDEEQLLSEAGK | 491 | Q3SY00 | |
| LDQIDIDVGFDKGLD | 246 | B7U540 | |
| IDNLEKAELLQGGDL | 106 | Q12981 | |
| IQQAEDGLKEFDAGI | 6526 | Q8NF91 | |
| GTENDVELKGALDLE | 471 | Q8NI08 | |
| NVKVLGGEVDALLEE | 186 | Q9H9A7 | |
| NLKLEQQVDELEGAL | 1036 | Q9Y2K3 | |
| LEGFRELLDKAQVGQ | 231 | Q9Y6C5 | |
| VIEANLDGELNLKIE | 181 | O60921 | |
| ELLEVGILDEQAVQG | 246 | P58107 | |
| GGSDQKDLVQELQEE | 131 | Q00987 | |
| DQGELEQLNAELGLE | 496 | Q8NC44 | |
| QVEAIEGGALQKLLV | 261 | Q9H173 | |
| DKLLAGDEIVGINDI | 66 | Q13796 | |
| LALGLQEEGEKVVSL | 186 | Q9BRY0 | |
| LVELSKAQDIEAGDG | 91 | P50991 | |
| SVGEEAKIILGQEQD | 61 | A8MV57 | |
| LEVKEENGVLVLNDA | 56 | P13667 | |
| VQEFLKDGDDVIIIG | 296 | P13667 | |
| VILNLDEENKGLGTL | 311 | Q8NEZ3 | |
| IAEEIKNLVGALDEG | 386 | Q53LP3 | |
| GQLDEKEKDLVGLAQ | 421 | O94844 | |
| LGKDGLAQELANEIR | 601 | Q13017 | |
| VNDGLKAELEIFGEQ | 191 | A8MT33 | |
| RDLQKELDGIIQDGV | 656 | Q8IYB8 | |
| VLGDVNGDKLTDVAI | 526 | P11215 | |
| DIGGLDNQIQEIKES | 186 | P62191 | |
| TSIGIDNLGLKLEEN | 351 | Q8IXU6 | |
| IQDNGTGIRKEDLDI | 61 | P40692 | |
| QSVGLQGLEKEELED | 226 | Q9Y2I6 | |
| LKSEVIGDGNQIEIE | 336 | Q9NSD9 | |
| LEDDGKLPEDQVQAI | 91 | Q9NRP7 | |
| QLLTKDEGEGTLELA | 256 | Q7Z5H3 | |
| LVSIGAEEIVDGNLK | 121 | Q08043 | |
| KLLQEINKGGIDAVE | 511 | Q8NHS4 | |
| IINEGKLAVVADDGV | 521 | Q16281 | |
| DLVKEELNIIQGALE | 426 | Q9H8M5 | |
| KENADLAGELRVLGQ | 1231 | P35749 | |
| QGELTGDELEHIAQK | 31 | Q9NNX1 | |
| EGLDLVSAKDLAGQL | 656 | O95398 | |
| GLIEANGELKVFIDQ | 6 | Q14186 | |
| EIIVNAKTLDGGLNV | 351 | Q16851 | |
| KLIDGQVIQLEDGSA | 71 | P52747 | |
| DTGELIVEELLLNGK | 101 | Q9BUI4 | |
| VSIEELENQELVGKG | 16 | Q9Y572 | |
| LQGEANGLDEVKVES | 66 | A8MU46 | |
| LEKDVLEGGNLRNAL | 366 | Q5PRF9 | |
| IAEELKGTEQELIGL | 456 | Q15431 | |
| RQNDKIDGEEGLFLL | 366 | Q9BSJ1 | |
| SDIGGLDKQIQELVE | 186 | P17980 | |
| ILGEGRLALEKANQE | 176 | O15067 | |
| GIDLGSLVDNEVDLK | 406 | Q12772 | |
| LNIVDQEGSLLGKGE | 216 | Q8IX01 | |
| LVDGDQSKILISGLE | 3601 | P22105 | |
| VGNEQFLEEEGKAVL | 106 | Q8IYQ7 | |
| GEALVGNEAVDQLVK | 551 | P08240 | |
| GQIEKLEDRGLDLDQ | 181 | A6NFE2 | |
| KNGDGLLNIEEIHQL | 156 | Q4KWH8 | |
| KLGEGALVNDVLQEL | 26 | A2A288 | |
| VAELGELGLVQFKDL | 26 | Q9HBG4 | |
| NLLSLDGLDNEVKDG | 276 | Q9Y2L5 | |
| DLKALQSVGQIVGEV | 46 | P62333 | |
| LLEDELDKSVQGTGL | 426 | Q9H1V8 | |
| GAQEKTNLEIIILVG | 756 | P35968 | |
| NQNEKIDGEDGLFLL | 366 | A6NDI0 | |
| ALAEAGVGLEEIAKQ | 166 | Q3LXA3 | |
| ELNKQANGLIEELEG | 161 | O15016 | |
| LEVVQSGGKNIELAV | 196 | O14818 | |
| GDTIGVKNLLIDDDD | 1161 | Q9NVE5 | |
| KGEGQLTNLELDEEV | 31 | Q6BDS2 | |
| EKLLEGQVIQLEDGT | 26 | P36508 | |
| GDLIGANLSIKDQVI | 611 | Q96L42 | |
| ILDLGENDLQDDGVK | 956 | Q86W25 | |
| SLDLGNNDLQDDGVK | 961 | Q86W24 | |
| QEQEEDGGSQLILEK | 296 | Q9NR99 | |
| DALQQVEEIGLEKAA | 1126 | Q9ULV0 | |
| GNLGLLEQAIALKAE | 376 | Q01538 |